Vascular targeting of nanocarriers: Perplexing aspects of the seemingly straightforward paradigm

ACS Nano

Volumn 8, Issue 5, 2014, Pages 4100-4132

  Howard, Melissa ^a   Zern, Blaine J ^a   Anselmo, Aaron C ^b   Shuvaev, Vladimir V ^a   Mitragotri, Samir ^b   Muzykantov, Vladimir ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b University of California   (United States)

Author keywords

ACE; cell adhesion molecules; drug targeting; endothelium; ICAM 1; intracellular delivery; nanocarriers; nanomedicine; nanoparticles; PECAM

Indexed keywords

BINDING SITES; BLOOD VESSELS; ENDOTHELIAL CELLS; ENZYME ACTIVITY; MEDICAL NANOTECHNOLOGY; MOLECULAR BIOLOGY; NANOPARTICLES; PATHOLOGY;

ACE; CELL ADHESION MOLECULES; DRUG-TARGETING; ENDOTHELIUM; ICAM-1; INTRACELLULAR DELIVERY; NANO-CARRIERS; PECAM;

MOLECULES;

CD31 ANTIGEN; CELL ADHESION MOLECULE; ENZYME; INTERCELLULAR ADHESION MOLECULE 1; LIGAND; NANOPARTICLE; PROTEIN BINDING;

ANIMAL; BINDING SITE; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECTS; HUMAN; HYDRODYNAMICS; NANOMEDICINE; PHENOTYPE; PHYSIOLOGY; PROCEDURES; VASCULAR ENDOTHELIUM;

ANIMALS; ANTIGENS, CD31; BINDING SITES; CELL ADHESION MOLECULES; DRUG DELIVERY SYSTEMS; ENDOTHELIUM, VASCULAR; ENZYMES; HUMANS; HYDRODYNAMICS; INTERCELLULAR ADHESION MOLECULE-1; LIGANDS; NANOMEDICINE; NANOPARTICLES; PHENOTYPE; PROTEIN BINDING;

EID: 84901649581     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn500136z     Document Type: Review

References (383)

1. Farokhzad, O. C.; Langer, R. Impact of Nanotechnology on Drug Delivery ACS Nano 2009, 3, 16-20
2. Langer, R. Drug Delivery and Targeting Nature 1998, 392, 5-10
3. Wood, K. C.; Azarin, S. M.; Arap, W.; Pasqualini, R.; Langer, R.; Hammond, P. T. Tumor-Targeted Gene Delivery Using Molecularly Engineered Hybrid Polymers Functionalized with a Tumor-Homing Peptide Bioconjugate Chem. 2008, 19, 403-405
4. Davis, M. E. The First Targeted Delivery of Sirna in Humans via a Self-Assembling, Cyclodextrin Polymer-Based Nanoparticle: From Concept to Clinic Mol. Pharmaceutics 2009, 6, 659-668
5. Lee, J. B.; Zhang, K.; Tam, Y. Y. C.; Tam, Y. K.; Belliveau, N. M.; Sung, V. Y. C.; Lin, P. J. C.; LeBlanc, E.; Ciufolini, M. A.; Rennie, P. S. et al. Lipid Nanoparticle Sirna Systems for Silencing the Androgen Receptor in Human Prostate Cancer in Vivo Int. J. Cancer 2012, 131, E781-E790
6. Pagano, R. E.; Weinstein, J. N. Interactions of Liposomes with Mammalian Cells Annu. Rev. Biophys. Bioeng. 1978, 7, 435-468
7. Gregoriadis, G. Liposomes in Therapeutic and Preventive Medicine: The Development of the Drug-Carrier Concept Ann. N.Y. Acad. Sci. 1978, 308, 343-370
8. Ryman, B. E.; Tyrrell, D. A. Liposomes-Methodology and Applications Front. Biol. 1979, 48, 549-574
9. Juliano, R. L. Drug Delivery Systems: A Brief Review Can. J. Physiol. Pharmacol. 1978, 56, 683-690
10. Langer, R. S.; Peppas, N. A. Present and Future Applications of Biomaterials in Controlled Drug Delivery Systems Biomaterials 1981, 2, 201-214
11. Elsabahy, M.; Wooley, K. L. Design of Polymeric Nanoparticles for Biomedical Delivery Applications Chem. Soc. Rev. 2012, 41, 2545-2561
12. Perry, J. L.; Herlihy, K. P.; Napier, M. E.; Desimone, J. M. Print: A Novel Platform toward Shape and Size Specific Nanoparticle Theranostics Acc. Chem. Res. 2011, 44, 990-998
13. Sawant, R. R.; Torchilin, V. P. Multifunctionality of Lipid-Core Micelles for Drug Delivery and Tumour Targeting Mol. Membr. Biol. 2010, 27, 232-246
14. Venkataraman, S.; Hedrick, J. L.; Ong, Z. Y.; Yang, C.; Ee, P. L.; Hammond, P. T.; Yang, Y. Y. The Effects of Polymeric Nanostructure Shape on Drug Delivery Adv. Drug Delivery Rev. 2011, 63, 1228-1246
15. van der Poll, D. G.; Kieler-Ferguson, H. M.; Floyd, W. C.; Guillaudeu, S. J.; Jerger, K.; Szoka, F. C.; Frechet, J. M. Design, Synthesis, and Biological Evaluation of a Robust, Biodegradable Dendrimer Bioconjugate Chem. 2010, 21, 764-773
16. Szoka, F., Jr.; Papahadjopoulos, D. Comparative Properties and Methods of Preparation of Lipid Vesicles (Liposomes) Annu. Rev. Biophys. Bioeng. 1980, 9, 467-508
17. Percec, V.; Wilson, D. A.; Leowanawat, P.; Wilson, C. J.; Hughes, A. D.; Kaucher, M. S.; Hammer, D. A.; Levine, D. H.; Kim, A. J.; Bates, F. S. et al. Self-Assembly of Janus Dendrimers into Uniform Dendrimersomes and Other Complex Architectures Science 2010, 328, 1009-1014
18. Eniola, A. O.; Hammer, D. A. Characterization of Biodegradable Drug Delivery Vehicles with the Adhesive Properties of Leukocytes II: Effect of Degradation on Targeting Activity Biomaterials 2005, 26, 661-670
19. Discher, B. M.; Won, Y. Y.; Ege, D. S.; Lee, J. C.; Bates, F. S.; Discher, D. E.; Hammer, D. A. Polymersomes: Tough Vesicles Made from Diblock Copolymers Science 1999, 284, 1143-1146
20. Liong, M.; Lu, J.; Kovochich, M.; Xia, T.; Ruehm, S. G.; Nel, A. E.; Tamanoi, F.; Zink, J. I. Multifunctional Inorganic Nanoparticles for Imaging, Targeting, and Drug Delivery ACS Nano 2008, 2, 889-896
21. Wang, Y.; Mirkin, C. A.; Park, S. J. Nanofabrication Beyond Electronics ACS Nano 2009, 3, 1049-1056
22. Bayer, C. L.; Peppas, N. A. Advances in Recognitive, Conductive and Responsive Delivery Systems J. Controlled Release 2008, 132, 216-221
23. Kieler-Ferguson, H. M.; Frechet, J. M.; Szoka, F. C., Jr. Clinical Developments of Chemotherapeutic Nanomedicines: Polymers and Liposomes for Delivery of Camptothecins and Platinum (II) Drugs Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol. 2013, 5, 130-138
24. Batrakova, E. V.; Kabanov, A. V. Pluronic Block Copolymers: Evolution of Drug Delivery Concept from Inert Nanocarriers to Biological Response Modifiers J. Controlled Release 2008, 130, 98-106
25. Leucuta, S. E. Systemic and Biophase Bioavailability and Pharmacokinetics of Nanoparticulate Drug Delivery Systems Curr. Drug Delivery 2013, 10, 208-240
26. Fraley, R.; Papahadjopoulos, D. Liposomes: The Development of a New Carrier System for Introducing Nucleic Acid into Plant and Animal Cells Curr. Top. Microbiol. Immunol. 1982, 96, 171-191
27. Maeda, H. Macromolecular Therapeutics in Cancer Treatment: The Epr Effect and Beyond J. Controlled Release 2012, 164, 138-144
28. Uliel, L.; Royal, H. D.; Darcy, M. D.; Zuckerman, D. A.; Sharma, A.; Saad, N. E. From the Angio Suite to the Gamma-Camera: Vascular Mapping and 99mTc-MAA Hepatic Perfusion Imaging before Liver Radioembolization-A Comprehensive Pictorial Review J. Nucl. Med. 2012, 53, 1736-1747
29. Huo, D.; Deng, S.; Li, L.; Ji, J. Studies on the Poly(lactic- co -glycolic) Acid Microspheres of Cisplatin for Lung-Targeting Int. J. Pharm. 2005, 289, 63-67
30. Muller, D. W.; Gordon, D.; San, H.; Yang, Z.; Pompili, V. J.; Nabel, G. J.; Nabel, E. G. Catheter-Mediated Pulmonary Vascular Gene Transfer and Expression Circ. Res. 1994, 75, 1039-1049
31. Huang, R. B.; Mocherla, S.; Heslinga, M. J.; Charoenphol, P.; Eniola-Adefeso, O. Dynamic and Cellular Interactions of Nanoparticles in Vascular-Targeted Drug Delivery Mol. Membr. Biol. 2010, 27, 312-327
32. Corti, A.; Pastorino, F.; Curnis, F.; Arap, W.; Ponzoni, M.; Pasqualini, R. Targeted Drug Delivery and Penetration into Solid Tumors Med. Res. Rev. 2012, 32, 1078-1091
33. Wickline, S. A.; Neubauer, A. M.; Winter, P. M.; Caruthers, S. D.; Lanza, G. M. Molecular Imaging and Therapy of Atherosclerosis with Targeted Nanoparticles J. Magn. Reson. Imaging 2007, 25, 667-680
34. Noble, C. O.; Kirpotin, D. B.; Hayes, M. E.; Mamot, C.; Hong, K.; Park, J. W.; Benz, C. C.; Marks, J. D.; Drummond, D. C. Development of Ligand-Targeted Liposomes for Cancer Therapy Expert. Opin. Ther. Targets 2004, 8, 335-353
35. Xia, W.; Low, P. S. Folate-Targeted Therapies for Cancer J. Med. Chem. 2010, 53, 6811-6824
36. Saravanakumar, G.; Kim, K.; Park, J. H.; Rhee, K.; Kwon, I. C. Current Status of Nanoparticle-Based Imaging Agents for Early Diagnosis of Cancer and Atherosclerosis J. Biomed. Nanotechnol. 2009, 5, 20-35
37. Simone, E.; Ding, B. S.; Muzykantov, V. Targeted Delivery of Therapeutics to Endothelium Cell Tissue Res. 2009, 335, 283-300
38. Muro, S.; Muzykantov, V. R. Targeting of Antioxidant and Anti-Thrombotic Drugs to Endothelial Cell Adhesion Molecules Curr. Pharm. Des. 2005, 11, 2383-2401
39. Muro, S.; Koval, M.; Muzykantov, V. Endothelial Endocytic Pathways: Gates for Vascular Drug Delivery Curr. Vasc. Pharmacol. 2004, 2, 281-299
40. Muro, S. Challenges in Design and Characterization of Ligand-Targeted Drug Delivery Systems J. Controlled Release 2012, 164, 125-137
41. Muzykantov, V. R.; Radhakrishnan, R.; Eckmann, D. M. Dynamic Factors Controlling Targeting Nanocarriers to Vascular Endothelium Curr. Drug Metab. 2012, 13, 70
42. Muzykantov, V. R. Targeted Therapeutics and Nanodevices for Vascular Drug Delivery: Quo Vadis? IUBMB Life 2011, 63, 583-585
43. Muzykantov, V. R. Biomedical Aspects of Targeted Delivery of Drugs to Pulmonary Endothelium Expert Opin. Drug Delivery 2005, 2, 909-926
44. Igarashi, E. Factors Affecting Toxicity and Efficacy of Polymeric Nanomedicines Toxicol. Appl. Pharmacol. 2008, 229, 121-134
45. Wischke, C.; Kruger, A.; Roch, T.; Pierce, B. F.; Li, W.; Jung, F.; Lendlein, A. Endothelial Cell Response to (Co)Polymer Nanoparticles Depending on the Inflammatory Environment and Comonomer Ratio Eur. J. Pharm. Biopharm. 2013, 84, 288-296
46. Garcia, A. N.; Vogel, S. M.; Komarova, Y. A.; Malik, A. B. Permeability of Endothelial Barrier: Cell Culture and in Vivo Models Methods Mol. Biol. (N.Y., NY, U.S.) 2011, 763, 333-354
47. Aird, W. C. Endothelium in Health and Disease Pharmacol. Rep. 2008, 60, 139-143
48. Thomas, S. R.; Witting, P. K.; Drummond, G. R. Redox Control of Endothelial Function and Dysfunction: Molecular Mechanisms and Therapeutic Opportunities Antioxid. Redox Signaling 2008, 10, 1713-1765
49. Stan, R. V.; Tse, D.; Deharvengt, S. J.; Smits, N. C.; Xu, Y.; Luciano, M. R.; McGarry, C. L.; Buitendijk, M.; Nemani, K. V.; Elgueta, R. et al. The Diaphragms of Fenestrated Endothelia: Gatekeepers of Vascular Permeability and Blood Composition Dev. Cell 2011, 23, 1203-1218
50. Stan, R. V. Endothelial Stomatal and Fenestral Diaphragms in Normal Vessels and Angiogenesis J. Cell. Mol. Med. 2007, 11, 621-643
51. Feng, D.; Nagy, J. A.; Pyne, K.; Hammel, I.; Dvorak, H. F.; Dvorak, A. M. Pathways of Macromolecular Extravasation across Microvascular Endothelium in Response to Vpf/Vegf and Other Vasoactive Mediators Microcirculation 1999, 6, 23-44
52. Thomsen, L. B.; Lichota, J.; Eskehave, T. N.; Linemann, T.; Mortensen, J. H.; du Jardin, K. G.; Moos, T. Brain Delivery Systems via Mechanism Independent of Receptor-Mediated Endocytosis and Adsorptive-Mediated Endocytosis Curr. Pharm. Biotechnol. 2012, 13, 2349-2354
53. Feng, D.; Nagy, J. A.; Dvorak, H. F.; Dvorak, A. M. Ultrastructural Studies Define Soluble Macromolecular, Particulate, and Cellular Transendothelial Cell Pathways in Venules, Lymphatic Vessels, and Tumor-Associated Microvessels in Man and Animals Microsc. Res. Technol. 2002, 57, 289-326
54. Carver, L. A.; Schnitzer, J. E. Caveolae: Mining Little Caves for New Cancer Targets Nat. Rev. Cancer 2003, 3, 571-581
55. Dejana, E. Endothelial Adherens Junctions: Implications in the Control of Vascular Permeability and Angiogenesis J. Clin. Invest. 1996, 98, 1949-1953
56. Pardridge, W. M.; Buciak, J.; Yang, J.; Wu, D. Enhanced Endocytosis in Cultured Human Breast Carcinoma Cells and in Vivo Biodistribution in Rats of a Humanized Monoclonal Antibody after Cationization of the Protein J. Pharmacol. Exp. Ther. 1998, 286, 548-554
57. Predescu, D.; Vogel, S. M.; Malik, A. B. Functional and Morphological Studies of Protein Transcytosis in Continuous Endothelia Am. J. Physiol.: Lung Cell. Mol. Physiol. 2004, 287, L895-901
58. Simionescu, N. Cellular Aspects of Transcapillary Exchange Physiol. Rev. 1983, 63, 1536-1579
59. Wang, Z.; Tiruppathi, C.; Cho, J.; Minshall, R. D.; Malik, A. B. Delivery of Nanoparticle: Complexed Drugs across the Vascular Endothelial Barrier via Caveolae IUBMB Life 2011, 63, 659-667
60. Davies, P. F. Endothelial Mechanisms of Flow-Mediated Athero-Protection and Susceptibility Circ. Res. 2007, 101, 10-12
61. Kowalski, P. S.; Leus, N. G.; Scherphof, G. L.; Ruiters, M. H.; Kamps, J. A.; Molema, G. Targeted Sirna Delivery to Diseased Microvascular Endothelial Cells: Cellular and Molecular Concepts IUBMB Life 2011, 63, 648-658
62. Hood, E.; Simone, E.; Wattamwar, P.; Dziubla, T.; Muzykantov, V. Nanocarriers for Vascular Delivery of Antioxidants Nanomedicine (London, U.K.) 2011, 6, 1257-1272
63. Muzykantov, V. R. Immunotargeting of Drugs to the Pulmonary Vascular Endothelium as a Therapeutic Strategy Pathophysiology 1998, 5, 15-33
64. Oh, P.; Li, Y.; Yu, J.; Durr, E.; Krasinska, K. M.; Carver, L. A.; Testa, J. E.; Schnitzer, J. E. Subtractive Proteomic Mapping of the Endothelial Surface in Lung and Solid Tumours for Tissue-Specific Therapy Nature 2004, 429, 629-635
65. Schnitzer, J. E. Vascular Targeting as a Strategy for Cancer Therapy N. Engl. J. Med. 1998, 339, 472-474
66. Spragg, D. D.; Alford, D. R.; Greferath, R.; Larsen, C. E.; Lee, K. D.; Gurtner, G. C.; Cybulsky, M. I.; Tosi, P. F.; Nicolau, C.; Gimbrone, M. A., Jr. Immunotargeting of Liposomes to Activated Vascular Endothelial Cells: A Strategy for Site-Selective Delivery in the Cardiovascular System Proc. Natl. Acad. Sci. U.S.A. 1997, 94, 8795-8800
67. Kennel, S. J.; Lee, R.; Bultman, S.; Kabalka, G. Rat Monoclonal Antibody Distribution in Mice: An Epitope inside the Lung Vascular Space Mediates Very Efficient Localization Int. J. Radiat. Appl. Instrum., Part B 1990, 17, 193-200
68. McIntosh, D. P.; Tan, X. Y.; Oh, P.; Schnitzer, J. E. Targeting Endothelium and Its Dynamic Caveolae for Tissue-Specific Transcytosis in Vivo: A Pathway to Overcome Cell Barriers to Drug and Gene Delivery Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 1996-2001
69. Muzykantov, V. R.; Danilov, S. M. Targeting of Radiolabeled Monoclonal Antibody against Ace to the Pulmonary Endothelium. In Targeted Delivery of Imaging Agents; Torchilin, V., Ed. CRC Press: Roca Baton, FL, 1995; pp 465-485.
70. Goetz, D. J.; el-Sabban, M. E.; Hammer, D. A.; Pauli, B. U. Lu-Ecam-1-Mediated Adhesion of Melanoma Cells to Endothelium under Conditions of Flow Int. J. Cancer 1996, 65, 192-199
71. Huang, X.; Molema, G.; King, S.; Watkins, L.; Edgington, T. S.; Thorpe, P. E. Tumor Infarction in Mice by Antibody-Directed Targeting of Tissue Factor to Tumor Vasculature Science 1997, 275, 547-550
72. Stan, R. V.; Ghitescu, L.; Jacobson, B. S.; Palade, G. E. Isolation, Cloning, and Localization of Rat Pv-1, a Novel Endothelial Caveolar Protein J. Cell Biol. 1999, 145, 1189-1198
73. Rajotte, D.; Arap, W.; Hagedorn, M.; Koivunen, E.; Pasqualini, R.; Ruoslahti, E. Molecular Heterogeneity of the Vascular Endothelium Revealed by in Vivo Phage Display J. Clin. Invest. 1998, 102, 430-437
74. Danilov, S. M.; Muzykantov, V. R.; Martynov, A. V.; Atochina, E. N.; Sakharov, I.; Trakht, I. N.; Smirnov, V. N. Lung Is the Target Organ for a Monoclonal Antibody to Angiotensin-Converting Enzyme Lab. Invest. 1991, 64, 118-124
75. Pasqualini, R.; McDonald, D. M.; Arap, W. Vascular Targeting and Antigen Presentation Nat. Immunol. 2001, 2, 567-568
76. Muzykantov, V. R.; Atochina, E. N.; Ischiropoulos, H.; Danilov, S. M.; Fisher, A. B. Immunotargeting of Antioxidant Enzyme to the Pulmonary Endothelium Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 5213-5218
77. Reynolds, P. N.; Nicklin, S. A.; Kaliberova, L.; Boatman, B. G.; Grizzle, W. E.; Balyasnikova, I. V.; Baker, A. H.; Danilov, S. M.; Curiel, D. T. Combined Transductional and Transcriptional Targeting Improves the Specificity of Transgene Expression in Vivo Nat. Biotechnol. 2001, 19, 838-842
78. Hamilton, A. J.; Huang, S. L.; Warnick, D.; Rabbat, M.; Kane, B.; Nagaraj, A.; Klegerman, M.; McPherson, D. D. Intravascular Ultrasound Molecular Imaging of Atheroma Components in Vivo J. Am. Coll. Cardiol. 2004, 43, 453-460
79. Kastrup, C. J.; Nahrendorf, M.; Figueiredo, J. L.; Lee, H.; Kambhampati, S.; Lee, T.; Cho, S.-W.; Gorbatov, R.; Iwamoto, Y.; Dang, T. T. Painting Blood Vessels and Atherosclerotic Plaques with an Adhesive Drug Depot Proc. Natl. Acad. Sci. U.S.A. 2012, 109, 21444-21449
80. Majmudar, M. D.; Yoo, J.; Keliher, E. J.; Truelove, J. J.; Iwamoto, Y.; Sena, B.; Dutta, P.; Borodovsky, A.; Fitzgerald, K.; Di Carli, M. F. Polymeric Nanoparticle Pet/Mr Imaging Allows Macrophage Detection in Atherosclerotic Plaques Circ. Res. 2013, 112, 755-761
81. Schmieder, A. H.; Wang, K.; Zhang, H.; Senpan, A.; Pan, D.; Keupp, J.; Caruthers, S. D.; Wickline, S. A.; Shen, B.; Wagner, E. M. Characterization of Early Neovascular Response to Acute Lung Ischemia Using Simultaneous 19f/1h Mr Molecular Imaging Angiogenesis 2014, 17, 51-60
82. Pan, D.; Pramanik, M.; Senpan, A.; Allen, J. S.; Zhang, H.; Wickline, S. A.; Wang, L. V.; Lanza, G. M. Molecular Photoacoustic Imaging of Angiogenesis with Integrin-Targeted Gold Nanobeacons FASEB J. 2011, 25, 875-882
83. Lanza, G.; Winter, P.; Caruthers, S.; Hughes, M.; Hu, G.; Schmieder, A.; Wickline, S. Theragnostics for Tumor and Plaque Angiogenesis with Perfluorocarbon Nanoemulsions Angiogenesis 2010, 13, 189-202
84. Sadeghi, M. M.; Glover, D. K.; Lanza, G. M.; Fayad, Z. A.; Johnson, L. L. Imaging Atherosclerosis and Vulnerable Plaque J. Nucl. Med. 2010, 51, 51S-65S
85. Kim, Y.; Lobatto, M. E.; Kawahara, T.; Chung, B. L.; Mieszawska, A. J.; Sanchez-Gaytan, B. L.; Fay, F.; Senders, M. L.; Calcagno, C.; Becraft, J. et al. Probing Nanoparticle Translocation across the Permeable Endothelium in Experimental Atherosclerosis Proc. Natl. Acad. Sci. U.S.A. 2014, 111, 1078-1083
86. 18F] Fluoro- d -Mannose Positron Emission Tomography Imaging in Atherosclerosis Nat. Med. 2014, 20, 215-219
87. Kim, Y.; Fay, F.; Cormode, D. P.; Sanchez-Gaytan, B. L.; Tang, J.; Hennessy, E. J.; Ma, M.; Moore, K.; Farokhzad, O. C.; Fisher, E. A. Single Step Reconstitution of Multifunctional High-Density Lipoprotein-Derived Nanomaterials Using Microfluidics ACS Nano 2013, 7, 9975-9983
88. Mieszawska, A. J.; Kim, Y.; Gianella, A.; van Rooy, I.; Priem, B.; Labarre, M. P.; Ozcan, C.; Cormode, D. P.; Petrov, A.; Langer, R. Synthesis of Polymer-Lipid Nanoparticles for Image-Guided Delivery of Dual Modality Therapy Bioconjugate Chem. 2013, 24, 1429-1434
89. Hara, T.; Bhayana, B.; Thompson, B.; Kessinger, C. W.; Khatri, A.; McCarthy, J. R.; Weissleder, R.; Lin, C. P.; Tearney, G. J.; Jaffer, F. A. Molecular Imaging of Fibrin Deposition in Deep Vein Thrombosis Using Fibrin-Targeted near-Infrared Fluorescence JACC 2012, 5, 607-615
90. Shuvaev, V. V.; Ilies, M. A.; Simone, E.; Zaitsev, S.; Kim, Y.; Cai, S.; Mahmud, A.; Dziubla, T.; Muro, S.; Discher, D. E. et al. Endothelial Targeting of Antibody-Decorated Polymeric Filomicelles ACS Nano 2011, 5, 6991-6999
91. Haun, J. B.; Pepper, L. R.; Boder, E. T.; Hammer, D. A. Using Engineered Single-Chain Antibodies to Correlate Molecular Binding Properties and Nanoparticle Adhesion Dynamics Langmuir 2011, 27, 13701-13712
92. Haun, J. B.; Hammer, D. A. Quantifying Nanoparticle Adhesion Mediated by Specific Molecular Interactions Langmuir 2008, 24, 8821-8832
93. Eniola, A. O.; Krasik, E. F.; Smith, L. A.; Song, G.; Hammer, D. A. I-Domain of Lymphocyte Function-Associated Antigen-1 Mediates Rolling of Polystyrene Particles on ICAM-1 under Flow Biophys. J. 2005, 89, 3577-3588
94. Calderon, A. J.; Muzykantov, V.; Muro, S.; Eckmann, D. M. Flow Dynamics, Binding and Detachment of Spherical Carriers Targeted to ICAM-1 on Endothelial Cells Biorheology 2009, 46, 323-341
95. Scherpereel, A.; Rome, J. J.; Wiewrodt, R.; Watkins, S. C.; Harshaw, D. W.; Alder, S.; Christofidou-Solomidou, M.; Haut, E.; Murciano, J. C.; Nakada, M. et al. Platelet-Endothelial Cell Adhesion Molecule-1-Directed Immunotargeting to Cardiopulmonary Vasculature J. Pharmacol. Exp. Ther. 2002, 300, 777-786
96. Danielyan, K.; Ding, B.-S.; Gottstein, C.; Cines, D. B.; Muzykantov, V. R. Delivery of Anti-Platelet-Endothelial Cell Adhesion Molecule Single-Chain Variable Fragment-Urokinase Fusion Protein to the Cerebral Vasculature Lyses Arterial Clots and Attenuates Postischemic Brain Edema J. Pharmacol. Exp. Ther. 2007, 321, 947-952
97. Matter, C. M.; Schuler, P. K.; Alessi, P.; Meier, P.; Ricci, R.; Zhang, D.; Halin, C.; Castellani, P.; Zardi, L.; Hofer, C. K. Molecular Imaging of Atherosclerotic Plaques Using a Human Antibody against the Extra-Domain B of Fibronectin Circ. Res. 2004, 95, 1225-1233
98. Virmani, R.; Kolodgie, F. D.; Burke, A. P.; Finn, A. V.; Gold, H. K.; Tulenko, T. N.; Wrenn, S. P.; Narula, J. Atherosclerotic Plaque Progression and Vulnerability to Rupture Angiogenesis as a Source of Intraplaque Hemorrhage Arterioscler., Thromb., Vasc. Biol. 2005, 25, 2054-2061
99. Winter, P. M.; Neubauer, A. M.; Caruthers, S. D.; Harris, T. D.; Robertson, J. D.; Williams, T. A.; Schmieder, A. H.; Hu, G.; Allen, J. S.; Lacy, E. K. Endothelial Aνβ3 Integrin-Targeted Fumagillin Nanoparticles Inhibit Angiogenesis in Atherosclerosis Arterioscler., Thromb., Vasc. Biol. 2006, 26, 2103-2109
100. Moreno, P. R.; Purushothaman, K.-R.; Sirol, M.; Levy, A. P.; Fuster, V. Neovascularization in Human Atherosclerosis Circulation 2006, 113, 2245-2252
101. Gerrit, L.; Sijbrands, E. J.; Valkema, R.; Folkert, J.; Feinstein, S. B.; Van der Steen, A. F.; Daemen, M. J.; Schinkel, A. F. Molecular Imaging of Inflammation and Intraplaque Vasa Vasorum: A Step Forward to Identification of Vulnerable Plaques? J. Nucl. Cardiol 2010, 17, 897-912
102. Schinkel, A. F.; Krueger, C. G.; Tellez, A.; Granada, J. F.; Reed, J. D.; Hall, A.; Zang, W.; Owens, C.; Kaluza, G. L.; Staub, D. Contrast-Enhanced Ultrasound for Imaging Vasa Vasorum: Comparison with Histopathology in a Swine Model of Atherosclerosis Eur. J. Echocardiogr. 2010, 11, 659-664
103. Korin, N.; Kanapathipillai, M.; Matthews, B. D.; Crescente, M.; Brill, A.; Mammoto, T.; Ghosh, K.; Jurek, S.; Bencherif, S. A.; Bhatta, D. et al. Shear-Activated Nanotherapeutics for Drug Targeting to Obstructed Blood Vessels Science 2012, 337, 738-742
104. Owens, D. E., III; Peppas, N. A. Opsonization, Biodistribution, and Pharmacokinetics of Polymeric Nanoparticles Int. J. Pharm. 2006, 307, 93-102
105. Roser, M.; Fischer, D.; Kissel, T. Surface-Modified Biodegradable Albumin Nano- and Microspheres. II: Effect of Surface Charges on in Vitro Phagocytosis and Biodistribution in Rats Eur. J. Pharm. Biopharm. 1998, 46, 255-63
106. Carrstensen, H.; Muller, R. H.; Muller, B. W. Particle Size, Surface Hydrophobicity and Interaction with Serum of Parenteral Fat Emulsions and Model Drug Carriers as Parameters Related to Res Uptake Clin. Nutr. 1992, 11, 289-97
107. Howard, M. D.; Jay, M.; Dziubla, T. D.; Lu, X. Pegylation of Nanocarrier Drug Delivery Systems: State of the Art J. Biomed. Nanotechnol. 2008, 4, 133-148
108. Gref, R.; Minamitake, Y.; Peracchia, M. T.; Trubetskoy, V.; Torchilin, V.; Langer, R. Biodegradable Long-Circulating Polymeric Nanospheres Science 1994, 263, 1600-1603
109. Mori, A.; Klibanov, A. L.; Torchilin, V. P.; Huang, L. Influence of the Steric Barrier Activity of Amphipathic Poly(Ethyleneglycol) and Ganglioside Gm1 on the Circulation Time of Liposomes and on the Target Binding of Immunoliposomes in Vivo FEBS Lett. 1991, 284, 263-266
110. Torchilin, V. P.; Klibanov, A. L.; Huang, L.; O'Donnell, S.; Nossiff, N. D.; Khaw, B. A. Targeted Accumulation of Polyethylene Glycol-Coated Immunoliposomes in Infarcted Rabbit Myocardium FASEB J. 1992, 6, 2716-2719
111. Klibanov, A. L.; Maruyama, K.; Beckerleg, A. M.; Torchilin, V. P.; Huang, L. Activity of Amphipathic Poly(Ethylene Glycol) 5000 to Prolong the Circulation Time of Liposomes Depends on the Liposome Size and Is Unfavorable for Immunoliposome Binding to Target Biochim. Biophys. Acta 1991, 1062, 142-148
112. Sawant, R. R.; Sawant, R. M.; Kale, A. A.; Torchilin, V. P. The Architecture of Ligand Attachment to Nanocarriers Controls Their Specific Interaction with Target Cells J. Drug Targeting 2008, 16, 596-600
113. Biswas, S.; Dodwadkar, N. S.; Sawant, R. R.; Torchilin, V. P. Development of the Novel Peg-Pe-Based Polymer for the Reversible Attachment of Specific Ligands to Liposomes: Synthesis and in Vitro Characterization Bioconjugate Chem. 2011, 22, 2005-2013
114. Liu, J.; Huang, Y.; Kumar, A.; Tan, A.; Jin, S.; Mozhi, A.; Liang, X. J. Ph-Sensitive Nano-Systems for Drug Delivery in Cancer Therapy Biotechnol. Adv. 2013, 10.1016/j.biotechadv.2013.11.009
115. Ishida, T.; Maeda, R.; Ichihara, M.; Mukai, Y.; Motoki, Y.; Manabe, Y.; Irimura, K.; Kiwada, H. The Accelerated Clearance on Repeated Injection of Pegylated Liposomes in Rats: Laboratory and Histopathological Study Cell. Mol. Biol. Lett. 2002, 7, 286
116. Ishida, T.; Maeda, R.; Ichihara, M.; Irimura, K.; Kiwada, H. Accelerated Clearance of Pegylated Liposomes in Rats after Repeated Injections J. Controlled Release 2003, 88, 35-42
117. Lu, W.; Wan, J.; She, Z.; Jiang, X. Brain Delivery Property and Accelerated Blood Clearance of Cationic Albumin Conjugated Pegylated Nanoparticle J. Controlled Release 2007, 118, 38-53
118. Ishida, T.; Ichihara, M.; Wang, X.; Yamamoto, K.; Kimura, J.; Majima, E.; Kiwada, H. Injection of Pegylated Liposomes in Rats Elicits Peg-Specific Igm, Which Is Responsible for Rapid Elimination of a Second Dose of Pegylated Liposomes J. Controlled Release 2006, 112, 15-25
119. Dams, E. T.; Laverman, P.; Oyen, W. J.; Storm, G.; Scherphof, G. L.; van Der Meer, J. W.; Corstens, F. H.; Boerman, O. C. Accelerated Blood Clearance and Altered Biodistribution of Repeated Injections of Sterically Stabilized Liposomes J. Pharmacol. Exp. Ther. 2000, 292, 1071-1079
120. Laverman, P.; Carstens, M. G.; Boerman, O. C.; Dams, E. T.; Oyen, W. J.; van Rooijen, N.; Corstens, F. H.; Storm, G. Factors Affecting the Accelerated Blood Clearance of Polyethylene Glycol-Liposomes Upon Repeated Injection J. Pharmacol. Exp. Ther. 2001, 298, 607-612
121. Ishida, T.; Ichihara, M.; Wang, X.; Kiwada, H. Spleen Plays an Important Role in the Induction of Accelerated Blood Clearance of Pegylated Liposomes J. Controlled Release 2006, 115, 243-250
122. Zandvoort, A.; Timens, W. The Dual Function of the Splenic Marginal Zone: Essential for Initiation of Anti-Ti-2 Responses but Also Vital in the General First-Line Defense against Blood-Borne Antigens Clin. Exp. Immunol. 2002, 130, 4-11
123. Ichihara, M.; Shimizu, T.; Imoto, A.; Hashiguchi, Y.; Uehara, Y.; Ishida, T.; Kiwada, H. Anti-Peg Igm Response against Pegylated Liposomes in Mice and Rats Pharmaceutics 2010, 3, 1-11
124. Park, Y. S.; Huang, L. Effect of Chemically Modified Gm1 and Neoglycolipid Analogs of Gm1 on Liposome Circulation Time: Evidence Supporting the Dysopsonin Hypothesis Biochim. Biophys. Acta 1993, 1166, 105-114
125. Michalek, M. T.; Mold, C.; Bremer, E. G. Inhibition of the Alternative Pathway of Human Complement by Structural Analogues of Sialic Acid J. Immunol. 1988, 140, 1588-1594
126. Shichijo, S.; Alving, C. R. Inhibitory Effects of Gangliosides on Immune Reactions of Antibodies to Neutral Glycolipids in Liposomes Biochim. Biophys. Acta 1986, 858, 118-124
127. Rodriguez, P. L.; Harada, T.; Christian, D. A.; Pantano, D. A.; Tsai, R. K.; Discher, D. E. Minimal "Self" Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of Nanoparticles Science 2013, 339, 971-975
128. Stachelek, S. J.; Finley, M. J.; Alferiev, I. S.; Wang, F.; Tsai, R. K.; Eckells, E. C.; Tomczyk, N.; Connolly, J. M.; Discher, D. E.; Eckmann, D. M. et al. The Effect of Cd47 Modified Polymer Surfaces on Inflammatory Cell Attachment and Activation Biomaterials 2011, 32, 4317-4326
129. Tsai, R. K.; Rodriguez, P. L.; Discher, D. E. Self Inhibition of Phagocytosis: The Affinity of 'Marker of Self' Cd47 for Sirpalpha Dictates Potency of Inhibition but Only at Low Expression Levels Blood Cells Mol., Dis. 2010, 45, 67-74
130. Subramanian, S.; Parthasarathy, R.; Sen, S.; Boder, E. T.; Discher, D. E. Species- and Cell Type-Specific Interactions between Cd47 and Human Sirpalpha Blood 2006, 107, 2548-2556
131. Hu, C. M.; Zhang, L.; Aryal, S.; Cheung, C.; Fang, R. H.; Zhang, L. Erythrocyte Membrane-Camouflaged Polymeric Nanoparticles as a Biomimetic Delivery Platform Proc. Natl. Acad. Sci. U.S.A. 2011, 108, 10980-10985
132. Parodi, A.; Quattrocchi, N.; van de Ven, A. L.; Chiappini, C.; Evangelopoulos, M.; Martinez, J. O.; Brown, B. S.; Khaled, S. Z.; Yazdi, I. K.; Enzo, M. V. et al. Synthetic Nanoparticles Functionalized with Biomimetic Leukocyte Membranes Possess Cell-Like Functions Nat. Nanotechnol. 2013, 8, 61-68
133. Choi, H. S.; Liu, W.; Misra, P.; Tanaka, E.; Zimmer, J. P.; Ipe, B. I.; Bawendi, M. G.; Frangioni, J. V. Renal Clearance of Quantum Dots Nat. Biotechnol. 2007, 25, 1165-1170
134. Predescu, S. A.; Predescu, D. N.; Malik, A. B. Molecular Determinants of Endothelial Transcytosis and Their Role in Endothelial Permeability Am. J. Physiol.: Lung Cell. Mol. Physiol. 2007, 293, L823-L842
135. Oh, P.; Borgstrom, P.; Witkiewicz, H.; Li, Y.; Borgstrom, B. J.; Chrastina, A.; Iwata, K.; Zinn, K. R.; Baldwin, R.; Testa, J. E. et al. Live Dynamic Imaging of Caveolae Pumping Targeted Antibody Rapidly and Specifically across Endothelium in the Lung Nat. Biotechnol. 2007, 25, 327-337
136. Shuvaev, V. V.; Tliba, S.; Pick, J.; Arguiri, E.; Christofidou-Solomidou, M.; Albelda, S. M.; Muzykantov, V. R. Modulation of Endothelial Targeting by Size of Antibody-Antioxidant Enzyme Conjugates J. Controlled Release 2011, 149, 236-241
137. Daum, N.; Tscheka, C.; Neumeyer, A.; Schneider, M. Novel Approaches for Drug Delivery Systems in Nanomedicine: Effects of Particle Design and Shape Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol. 2012, 4, 52-65
138. Simone, E. A.; Dziubla, T. D.; Muzykantov, V. R. Polymeric Carriers: Role of Geometry in Drug Delivery Expert Opin. Drug Delivery 2008, 5, 1283-1300
139. Liu, Y.; Tan, J.; Thomas, A.; Ou-Yang, D.; Muzykantov, V. R. The Shape of Things to Come: Importance of Design in Nanotechnology for Drug Delivery Ther. Delivery 2012, 3, 181-194
140. Champion, J. A.; Katare, Y. K.; Mitragotri, S. Particle Shape: A New Design Parameter for Micro- and Nanoscale Drug Delivery Carriers J. Controlled Release 2007, 121, 3-9
141. Mitragotri, S. In Drug Delivery, Shape Does Matter Pharm. Res. 2009, 26, 232-234
142. Herd, H.; Daum, N.; Jones, A. T.; Huwer, H.; Ghandehari, H.; Lehr, C. M. Nanoparticle Geometry and Surface Orientation Influence Mode of Cellular Uptake ACS Nano 2013, 7, 1961-1973
143. Muro, S.; Garnacho, C.; Champion, J. A.; Leferovich, J.; Gajewski, C.; Schuchman, E. H.; Mitragotri, S.; Muzykantov, V. R. Control of Endothelial Targeting and Intracellular Delivery of Therapeutic Enzymes by Modulating the Size and Shape of ICAM-1-Targeted Carriers Mol. Ther. 2008, 16, 1450-1458
144. Champion, J. A.; Mitragotri, S. Shape Induced Inhibition of Phagocytosis of Polymer Particles Pharm. Res. 2009, 26, 244-249
145. Champion, J.; Mitragotri, S. Role of Target Geometry in Phagocytosis Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 4930-4934
146. Muzykantov, V. R. Drug Delivery by Red Blood Cells: Vascular Carriers Designed by Mother Nature Expert Opin. Drug Delivery 2010, 7, 403-427
147. Merkel, T. J.; Jones, S. W.; Herlihy, K. P.; Kersey, F. R.; Shields, A. R.; Napier, M.; Luft, J. C.; Wu, H.; Zamboni, W. C.; Wang, A. Z. et al. Using Mechanobiological Mimicry of Red Blood Cells to Extend Circulation Times of Hydrogel Microparticles Proc. Natl. Acad. Sci. U.S.A. 2011, 108, 586-591
148. Fung, Y.-c. Biomechanics: Mechanical Properties of Living Tissues; Springer: New York, 1993.
149. Merkel, T. J.; Chen, K.; Jones, S. W.; Pandya, A. A.; Tian, S.; Napier, M. E.; Zamboni, W. E.; DeDimone, J. M. The Effect of Particle Size on the Biodistribution of Low-Modulus Hydrogel Print Particles J. Controlled Release 2012, 162, 37-44
150. Simone, E. A.; Dziubla, T. D.; Colon-Gonzalez, F.; Discher, D. E.; Muzykantov, V. R. Effect of Polymer Amphiphilicity on Loading of a Therapeutic Enzyme into Protective Filamentous and Spherical Polymer Nanocarriers Biomacromolecules 2007, 8, 3914-3921
151. Geng, Y.; Dalhaimer, P.; Cai, S.; Tsai, R.; Tewari, M.; Minko, T.; Discher, D. E. Shape Effects of Filaments versus Spherical Particles in Flow and Drug Delivery Nat. Nanotechnol. 2007, 2, 249-255
152. Dalhaimer, P.; Engler, A. J.; Parthasarathy, R.; Discher, D. E. Targeted Worm Micelles Biomacromolecules 2004, 5, 1714-1719
153. Venditto, V. J.; Szoka, F. C., Jr. Cancer Nanomedicines: So Many Papers and So Few Drugs! Adv. Drug Delivery Rev. 2013, 65, 80-88
154. Pollinger, K.; Hennig, R.; Ohlmann, A.; Fuchshofer, R.; Wenzel, R.; Breunig, M.; Tessmar, J.; Tamm, E. R.; Goepferich, A. Ligand-Functionalized Nanoparticles Target Endothelial Cells in Retinal Capillaries after Systemic Application Proc. Natl. Acad. Sci. U.S.A. 2013, 110, 6115-6120
155. Brinkhuis, R. P.; Stojanov, K.; Laverman, P.; Eilander, J.; Zuhorn, I. S.; Rutjes, F. P.; van Hest, J. C. Size Dependent Biodistribution and Spect Imaging of (111) in-Labeled Polymersomes Bioconjugate Chem. 2012, 26, 958-965
156. Zern, B. J.; Chacko, A.-M.; Liu, J.; Greineder, C. F.; Blankemeyer, E. R.; Radhakrishnan, R.; Muzykantov, V. Reduction of Nanoparticle Avidity Enhances the Selectivity of Vascular Targeting and Pet Detection of Pulmonary Inflammation ACS Nano 2013, 7, 2461-2469
157. Rossin, R.; Muro, S.; Welch, M. J.; Muzykantov, V. R.; Schuster, D. P. In Vivo Imaging of 64cu-Labeled Polymer Nanoparticles Targeted to the Lung Endothelium J. Nucl. Med. 2008, 49, 103-111
158. Danilov, S. M.; Martynov, A. V.; Klibanov, A. L.; Slinkin, M. A.; Sakharov, I.; Malov, A. G.; Sergienko, V. B.; Vedernikov, A.; Muzykantov, V. R.; Torchilin, V. P. Radioimmunoimaging of Lung Vessels: An Approach Using Indium-111-Labeled Monoclonal Antibody to Angiotensin-Converting Enzyme J. Nucl. Med. 1989, 30, 1686-1692
159. Simone, E. A.; Zern, B. J.; Chacko, A. M.; Mikitsh, J. L.; Blankemeyer, E. R.; Muro, S.; Stan, R. V.; Muzykantov, V. R. Endothelial Targeting of Polymeric Nanoparticles Stably Labeled with the Pet Imaging Radioisotope Iodine-124 Biomaterials 2012, 33, 5406-5413
160. Muzykantov, V. R.; Christofidou-Solomidou, M.; Balyasnikova, I.; Harshaw, D. W.; Schultz, L.; Fisher, A. B.; Albelda, S. M. Streptavidin Facilitates Internalization and Pulmonary Targeting of an Anti-Endothelial Cell Antibody (Platelet-Endothelial Cell Adhesion Molecule 1): A Strategy for Vascular Immunotargeting of Drugs Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 2379-2384
161. Muzykantov, V. R.; Puchnina, E. A.; Atochina, E. N.; Hiemish, H.; Slinkin, M. A.; Meertsuk, F. E.; Danilov, S. M. Endotoxin Reduces Specific Pulmonary Uptake of Radiolabeled Monoclonal Antibody to Angiotensin-Converting Enzyme J. Nucl. Med. 1991, 32, 453-460
162. Pan, H.; Myerson, J. W.; Hu, L.; Marsh, J. N.; Hou, K.; Scott, M. J.; Allen, J. S.; Hu, G.; San Roman, S.; Lanza, G. M. et al. A. Programmable Nanoparticle Functionalization for in Vivo Targeting FASEB J. 2013, 27, 255-264
163. Muzykantov, V. R.; Gavriluk, V. D.; Reinecke, A.; Atochina, E. N.; Kuo, A.; Barnathan, E. S.; Fisher, A. B. The Functional Effects of Biotinylation of Anti-Angiotensin-Converting Enzyme Monoclonal Antibody in Terms of Targeting in Vivo Anal. Biochem. 1995, 226, 279-287
164. Tenzer, S.; Docter, D.; Rosfa, S.; Wlodarski, A.; Kuharev, J.; Rekik, A.; Knauer, S. K.; Bantz, C.; Nawroth, T.; Bier, C. et al. Nanoparticle Size Is a Critical Physicochemical Determinant of the Human Blood Plasma Corona: A Comprehensive Quantitative Proteomic Analysis ACS Nano 2011, 5, 7155-7167
165. Monopoli, M. P.; Aberg, C.; Salvati, A.; Dawson, K. A. Biomolecular Coronas Provide the Biological Identity of Nanosized Materials Nat. Nanotechnol. 2012, 7, 779-786
166. Andersen, A. J.; Hashemi, S. H.; Andresen, T. L.; Hunter, A. C.; Moghimi, S. M. Complement: Alive and Kicking Nanomedicines J. Biomed. Nanotechnol. 2009, 5, 364-372
167. Salvati, A.; Pitek, A. S.; Monopoli, M. P.; Prapainop, K.; Bombelli, F. B.; Hristov, D. R.; Kelly, P. M.; Aberg, C.; Mahon, E.; Dawson, K. A. Transferrin-Functionalized Nanoparticles Lose Their Targeting Capabilities When a Biomolecule Corona Adsorbs on the Surface Nat. Nanotechnol. 2013, 8, 137-143
168. Lesniak, A.; Fenaroli, F.; Monopoli, M. P.; Aberg, C.; Dawson, K. A.; Salvati, A. Effects of the Presence or Absence of a Protein Corona on Silica Nanoparticle Uptake and Impact on Cells ACS Nano 2012, 6, 5845-5857
169. Tenzer, S.; Docter, D.; Kuharev, J.; Musyanovych, A.; Fetz, V.; Hecht, R.; Schlenk, F.; Fischer, D.; Kiouptsi, K.; Reinhardt, C. et al. Rapid Formation of Plasma Protein Corona Critically Affects Nanoparticle Pathophysiology Nat. Nanotechnol. 2013, 8, 772-781
170. Muzykantov, V. R.; Smirnov, M. D.; Samokhin, G. P. Avidin Attachment to Biotinylated Erythrocytes Induces Homologous Lysis via the Alternative Pathway of Complement Blood 1991, 78, 2611-2618
171. Lesniak, A.; Campbell, A.; Monopoli, M. P.; Lynch, I.; Salvati, A.; Dawson, K. A. Serum Heat Inactivation Affects Protein Corona Composition and Nanoparticle Uptake Biomaterials 2010, 31, 9511-9518
172. Muzykantov, V. R.; Smirnov, M. D.; Samokhin, G. P. Streptavidin-Induced Lysis of Homologous Biotinylated Erythrocytes. Evidence against the Key Role of the Avidin Charge in Complement Activation via the Alternative Pathway FEBS Lett. 1991, 280, 112-114
173. Durr, E.; Yu, J.; Krasinska, K. M.; Carver, L. A.; Yates, J. R.; Testa, J. E.; Oh, P.; Schnitzer, J. E. Direct Proteomic Mapping of the Lung Microvascular Endothelial Cell Surface in Vivo and in Cell Culture Nat. Biotechnol. 2004, 22, 985-992
174. Hajitou, A.; Trepel, M.; Lilley, C. E.; Soghomonyan, S.; Alauddin, M. M.; Marini, F. C., III; Restel, B. H.; Ozawa, M. G.; Moya, C. A.; Rangel, R. et al. A Hybrid Vector for Ligand-Directed Tumor Targeting and Molecular Imaging Cell 2006, 125, 385-398
175. Nicklin, S. A.; White, S. J.; Watkins, S. J.; Hawkins, R. E.; Baker, A. H. Selective Targeting of Gene Transfer to Vascular Endothelial Cells by Use of Peptides Isolated by Phage Display Circulation 2000, 102, 231-237
176. Christofidou-Solomidou, M.; Muzykantov, V. R. Antioxidant Strategies in Respiratory Medicine Treat. Respir. Med. 2006, 5, 47-78
177. Muzykantov, V. R. Targeting of Superoxide Dismutase and Catalase to Vascular Endothelium J. Controlled Release 2001, 71, 1-21
178. Pasqualini, R.; Arap, W.; McDonald, D. M. Probing the Structural and Molecular Diversity of Tumor Vasculature Trends Mol. Med. 2002, 8, 563-571
179. Danilov, S. M.; Gavrilyuk, V. D.; Franke, F. E.; Pauls, K.; Harshaw, D. W.; McDonald, T. D.; Miletich, D. J.; Muzykantov, V. R. Lung Uptake of Antibodies to Endothelial Antigens: Key Determinants of Vascular Immunotargeting Am. J. Physiol.: Lung Cell. Mol. Physiol. 2001, 280, L1335-13347
180. Shuvaev, V. V.; Christofidou-Solomidou, M.; Scherpereel, A.; Simone, E.; Arguiri, E.; Tliba, S.; Pick, J.; Kennel, S.; Albelda, S. M.; Muzykantov, V. R. Factors Modulating the Delivery and Effect of Enzymatic Cargo Conjugated with Antibodies Targeted to the Pulmonary Endothelium J. Controlled Release 2007, 118, 235-244
181. Keelan, E. T.; Harrison, A. A.; Chapman, P. T.; Binns, R. M.; Peters, A. M.; Haskard, D. O. Imaging Vascular Endothelial Activation: An Approach Using Radiolabeled Monoclonal Antibodies against the Endothelial Cell Adhesion Molecule E-Selectin J. Nucl. Med. 1994, 35, 276-281
182. Metzger, R.; Franke, F. E.; Bohle, R. M.; Alhenc-Gelas, F.; Danilov, S. M. Heterogeneous Distribution of Angiotensin I-Converting Enzyme (Cd143) in the Human and Rat Vascular Systems: Vessel, Organ and Species Specificity Microvasc. Res. 2011, 81, 206-215
183. Ford, V. A.; Stringer, C.; Kennel, S. J. Thrombomodulin Is Preferentially Expressed in Balb/C Lung Microvessels J. Biol. Chem. 1992, 267, 5446-5450
184. Carson-Walter, E. B.; Winans, B. N.; Whiteman, M. C.; Liu, Y.; Jarvela, S.; Haapasalo, H.; Tyler, B. M.; Huso, D. L.; Johnson, M. D.; Walter, K. A. Characterization of Tem1/Endosialin in Human and Murine Brain Tumors BMC Cancer 2009, 9, 417
185. Pasqualini, R.; Koivunen, E.; Kain, R.; Lahdenranta, J.; Sakamoto, M.; Stryhn, A.; Ashmun, R. A.; Shapiro, L. H.; Arap, W.; Ruoslahti, E. Aminopeptidase N Is a Receptor for Tumor-Homing Peptides and a Target for Inhibiting Angiogenesis Cancer Res. 2000, 60, 722-727
186. Pober, J. S.; Sessa, W. C. Evolving Functions of Endothelial Cells in Inflammation Nat. Rev. Immunol. 2007, 7, 803-815
187. Aird, W. C.; Edelberg, J. M.; Weiler-Guettler, H.; Simmons, W. W.; Smith, T. W.; Rosenberg, R. D. Vascular Bed-Specific Expression of an Endothelial Cell Gene Is Programmed by the Tissue Microenvironment J. Cell Bio. 1997, 138, 1117-1124
188. Aird, W. C. Phenotypic Heterogeneity of the Endothelium: I. Structure, Function, and Mechanisms Circ. Res. 2007, 100, 158-173
189. Newman, P. J.; Albelda, S. M. Cellular and Molecular Aspects of PECAM-1 Nouv. Rev. Fr. Hematol. 1992, 34 (Suppl.) S9-13
190. Giannotta, M.; Trani, M.; Dejana, E. Ve-Cadherin and Endothelial Adherens Junctions: Active Guardians of Vascular Integrity Dev. Cell 2013, 26, 441-454
191. Barreiro, O.; Yanez-Mo, M.; Sala-Valdes, M.; Gutierrez-Lopez, M. D.; Ovalle, S.; Higginbottom, A.; Monk, P. N.; Cabanas, C.; Sanchez-Madrid, F. Endothelial Tetraspanin Microdomains Regulate Leukocyte Firm Adhesion During Extravasation Blood 2005, 105, 2852-2861
192. Cook-Mills, J. M.; Marchese, M. E.; Abdala-Valencia, H. Vascular Cell Adhesion Molecule-1 Expression and Signaling During Disease: Regulation by Reactive Oxygen Species and Antioxidants Antioxid. Redox Signaling 2011, 15, 1607-1638
193. Almenar-Queralt, A.; Duperray, A.; Miles, L. A.; Felez, J.; Altieri, D. C. Apical Topography and Modulation of ICAM-1 Expression on Activated Endothelium Am. J. Pathol. 1995, 147, 1278-1288
194. Wright, M. D.; Moseley, G. W.; van Spriel, A. B. Tetraspanin Microdomains in Immune Cell Signalling and Malignant Disease Tissue Antigens 2004, 64, 533-542
195. Ghitescu, L.; Jacobson, B. S.; Crine, P. A Novel, 85 kDa Endothelial Antigen Differentiates Plasma Membrane Macrodomains in Lung Alveolar Capillaries Endothelium 1999, 6, 241-250
196. Murciano, J. C.; Harshaw, D. W.; Ghitescu, L.; Danilov, S. M.; Muzykantov, V. R. Vascular Immunotargeting to Endothelial Surface in a Specific Macrodomain in Alveolar Capillaries Am. J. Respir. Crit. Care Med. 2001, 164, 1295-1302
197. Garnacho, C.; Albelda, S. M.; Muzykantov, V. R.; Muro, S. Differential Intra-Endothelial Delivery of Polymer Nanocarriers Targeted to Distinct PECAM-1 Epitopes J. Controlled Release 2008, 130, 226-233
198. Mulivor, A. W.; Lipowsky, H. H. Role of Glycocalyx in Leukocyte-Endothelial Cell Adhesion Am. J. Physiol.: Heart Circ. Physiol. 2002, 283, H1282-1291
199. Skidgel, R. A. Bradykinin-Degrading Enzymes: Structure, Function, Distribution, and Potential Roles in Cardiovascular Pharmacology J. Cardiovasc. Pharmacol. 1992, 20 (Suppl 9) S4-9
200. Maruyama, K.; Kennel, S. J.; Huang, L. Lipid Composition Is Important for Highly Efficient Target Binding and Retention of Immunoliposomes Proc. Natl. Acad. Sci. U.S.A. 1990, 87, 5744-5748
201. Christofidou-Solomidou, M.; Kennel, S.; Scherpereel, A.; Wiewrodt, R.; Solomides, C. C.; Pietra, G. G.; Murciano, J. C.; Shah, S. A.; Ischiropoulos, H.; Albelda, S. M. et al. Vascular Immunotargeting of Glucose Oxidase to the Endothelial Antigens Induces Distinct Forms of Oxidant Acute Lung Injury: Targeting to Thrombomodulin, but Not to PECAM-1, Causes Pulmonary Thrombosis and Neutrophil Transmigration Am. J. Pathol. 2002, 160, 1155-1169
202. Esmon, C. T. Thrombomodulin as a Model of Molecular Mechanisms That Modulate Protease Specificity and Function at the Vessel Surface FASEB J. 1995, 9, 946-955
203. Brisson, C.; Archipoff, G.; Hartmann, M. L.; Hanau, D.; Beretz, A.; Freyssinet, J. M.; Cazenave, J. P. Antibodies to Thrombomodulin Induce Receptor-Mediated Endocytosis in Human Saphenous Vein Endothelial Cells Thromb. Haemost. 1992, 68, 737-743
204. Guermazi, S.; Mellouli, F.; Trabelsi, S.; Bejaoui, M.; Dellagi, K. Anti-Thrombomodulin Antibodies and Venous Thrombosis Blood Coagulation Fibrinolysis 2004, 15, 553-558
205. Christofidou-Solomidou, M.; Scherpereel, A.; Wiewrodt, R.; Ng, K.; Sweitzer, T.; Arguiri, E.; Shuvaev, V.; Solomides, C. C.; Albelda, S. M.; Muzykantov, V. R. PECAM-Directed Delivery of Catalase to Endothelium Protects against Pulmonary Vascular Oxidative Stress Am. J. Physiol.: Lung Cell. Mol. Physiol. 2003, 285, L283-292
206. 2 and Endothelial Oxidative Stress Am. J. Physiol. 1999, 277, L271-281
207. Chacko, A. M.; Hood, E. D.; Zern, B. J.; Muzykantov, V. R. Targeted Nanocarriers for Imaging and Therapy of Vascular Inflammation Curr. Opin. Colloid Interface Sci. 2011, 16, 215-227
208. Springer, T. A. Adhesion Receptors of the Immune System Nature 1990, 346, 425-434
209. Kumasaka, T.; Quinlan, W. M.; Doyle, N. A.; Condon, T. P.; Sligh, J.; Takei, F.; Beaudet, A.; Bennett, C. F.; Doerschuk, C. M. Role of the Intercellular Adhesion Molecule-1(ICAM-1) in Endotoxin-Induced Pneumonia Evaluated Using ICAM-1 Antisense Oligonucleotides, Anti-ICAM-1 Monoclonal Antibodies, and ICAM-1 Mutant Mice J. Clin. Invest. 1996, 97, 2362-2369
210. Kishimoto, T. K.; Rothlein, R. Integrins, ICAMs, and Selectins: Role and Regulation of Adhesion Molecules in Neutrophil Recruitment to Inflammatory Sites Adv. Pharmacol. 1994, 25, 117-169
211. Albelda, S. M. Endothelial and Epithelial Cell Adhesion Molecules Am. J. Respir. Cell Mol. Biol. 1991, 4, 195-203
212. Kelly, K. A.; Allport, J. R.; Tsourkas, A.; Shinde-Patil, V. R.; Josephson, L.; Weissleder, R. Detection of Vascular Adhesion Molecule-1 Expression Using a Novel Multimodal Nanoparticle Circ. Res. 2005, 96, 327-336
213. Cybulsky, M. I.; Gimbrone, M. A., Jr. Endothelial Expression of a Mononuclear Leukocyte Adhesion Molecule during Atherogenesis Science 1991, 251, 788-791
214. Taichman, D. B.; Cybulsky, M. I.; Djaffar, I.; Longenecker, B. M.; Teixido, J.; Rice, G. E.; Aruffo, A.; Bevilacqua, M. P. Tumor Cell Surface Alpha 4 Beta 1 Integrin Mediates Adhesion to Vascular Endothelium: Demonstration of an Interaction with the N-Terminal Domains of Incam-110/Vcam-1 Cell Regul. 1991, 2, 347-355
215. Tsourkas, A.; Shinde-Patil, V. R.; Kelly, K. A.; Patel, P.; Wolley, A.; Allport, J. R.; Weissleder, R. In Vivo Imaging of Activated Endothelium Using an Anti-Vcam-1 Magnetooptical Probe Bioconjugate Chem. 2005, 16, 576-581
216. Kuijpers, T. W.; Raleigh, M.; Kavanagh, T.; Janssen, H.; Calafat, J.; Roos, D.; Harlan, J. M. Cytokine-Activated Endothelial Cells Internalize E-Selectin into a Lysosomal Compartment of Vesiculotubular Shape. A Tubulin-Driven Process J. Immunol. 1994, 152, 5060-5069
217. Straley, K. S.; Green, S. A. Rapid Transport of Internalized P-Selectin to Late Endosomes and the Tgn: Roles in Regulating Cell Surface Expression and Recycling to Secretory Granules J. Cell Biol. 2000, 151, 107-116
218. von Asmuth, E. J.; Smeets, E. F.; Ginsel, L. A.; Onderwater, J. J.; Leeuwenberg, J. F.; Buurman, W. A. Evidence for Endocytosis of E-Selectin in Human Endothelial Cells Eur. J. Immunol. 1992, 22, 2519-2526
219. Kessner, S.; Krause, A.; Rothe, U.; Bendas, G. Investigation of the Cellular Uptake of E-Selectin-Targeted Immunoliposomes by Activated Human Endothelial Cells Biochim. Biophys. Acta 2001, 1514, 177-190
220. Kok, R. J.; Everts, M.; Asgeirsdottir, S. A.; Meijer, D. K.; Molema, G. Cellular Handling of a Dexamethasone-Anti-E-Selectin Immunoconjugate by Activated Endothelial Cells: Comparison with Free Dexamethasone Pharm. Res. 2002, 19, 1730-1735
221. Harari, O. A.; Wickham, T. J.; Stocker, C. J.; Kovesdi, I.; Segal, D. M.; Huehns, T. Y.; Sarraf, C.; Haskard, D. O. Targeting an Adenoviral Gene Vector to Cytokine-Activated Vascular Endothelium via E-Selectin Gene Ther. 1999, 6, 801-807
222. Lindner, J. R.; Song, J.; Christiansen, J.; Klibanov, A. L.; Xu, F.; Ley, K. Ultrasound Assessment of Inflammation and Renal Tissue Injury with Microbubbles Targeted to P-Selectin Circulation 2001, 104, 2107-2112
223. Lindner, J. R.; Klibanov, A. L.; Ley, K. Targeting Inflammation. In Biomedical Aspects of Drug Targeting; Muzykantov, V. R.; Torchilin, V. P., Eds.; Kluwer Academic Publishers: Boston, MA, 2003; pp 149-172.
224. Carpen, O.; Pallai, P.; Staunton, D. E.; Springer, T. A. Association of Intercellular Adhesion Molecule-1 (ICAM-1) with Actin-Containing Cytoskeleton and Alpha-Actinin J. Cell Biol. 1992, 118, 1223-1234
225. Treutiger, C. J.; Heddini, A.; Fernandez, V.; Muller, W. A.; Wahlgren, M. PECAM-1/Cd31, an Endothelial Receptor for Binding Plasmodium Falciparum-Infected Erythrocytes Nat. Med. 1997, 3, 1405-1408
226. Romer, L. H.; McLean, N. V.; Yan, H. C.; Daise, M.; Sun, J.; DeLisser, H. M. Ifn-Gamma and Tnf-Alpha Induce Redistribution of PECAM-1 (Cd31) on Human Endothelial Cells J. Immunol. 1995, 154, 6582-6592
227. Scalia, R.; Lefer, A. M. In Vivo Regulation of PECAM-1 Activity During Acute Endothelial Dysfunction in the Rat Mesenteric Microvasculature J. Leukocyte Biol. 1998, 64, 163-169
228. Muro, S.; Cui, X.; Gajewski, C.; Murciano, J. C.; Muzykantov, V. R.; Koval, M. Slow Intracellular Trafficking of Catalase Nanoparticles Targeted to ICAM-1 Protects Endothelial Cells from Oxidative Stress Am. J. Physiol.: Cell Physiol. 2003, 285, C1339-1347
229. Rothlein, R.; Wegner, C. Role of Intercellular Adhesion Molecule-1 in the Inflammatory Response Kidney Int. 1992, 41, 617-619
230. Hubbard, A. K.; Rothlein, R. Intercellular Adhesion Molecule-1 (ICAM-1) Expression and Cell Signaling Cascades Free Radical Biol. Med. 2000, 28, 1379-1386
231. Cao, M. Y.; Huber, M.; Beauchemin, N.; Famiglietti, J.; Albelda, S. M.; Veillette, A. Regulation of Mouse PECAM-1 Tyrosine Phosphorylation by the Src and Csk Families of Protein-Tyrosine Kinases J. Biol. Chem. 1998, 273, 15765-15772
232. Cao, G.; O'Brien, C. D.; Zhou, Z.; Sanders, S. M.; Greenbaum, J. N.; Makrigiannakis, A.; DeLisser, H. M. Involvement of Human PECAM-1 in Angiogenesis and in Vitro Endothelial Cell Migration Am. J. Physiol.: Cell Physiol. 2002, 282, C1181-1190
233. DeLisser, H. M.; Christofidou-Solomidou, M.; Strieter, R. M.; Burdick, M. D.; Robinson, C. S.; Wexler, R. S.; Kerr, J. S.; Garlanda, C.; Merwin, J. R.; Madri, J. A. et al. M. Involvement of Endothelial PECAM-1/Cd31 in Angiogenesis Am. J. Pathol. 1997, 151, 671-677
234. DeLisser, H. M.; Yan, H. C.; Newman, P. J.; Muller, W. A.; Buck, C. A.; Albelda, S. M. Platelet/Endothelial Cell Adhesion Molecule-1 (Cd31)-Mediated Cellular Aggregation Involves Cell Surface Glycosaminoglycans J. Biol. Chem. 1993, 268, 16037-16046
235. Diamond, M. S.; Staunton, D. E.; de Fougerolles, A. R.; Stacker, S. A.; Garcia-Aguilar, J.; Hibbs, M. L.; Springer, T. A. ICAM-1 (Cd54): A Counter-Receptor for Mac-1 (Cd11b/Cd18) J. Cell Biol. 1990, 111, 3129-3139
236. Jun, C. D.; Shimaoka, M.; Carman, C. V.; Takagi, J.; Springer, T. A. Dimerization and the Effectiveness of ICAM-1 in Mediating Lfa-1-Dependent Adhesion Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 6830-6835
237. Nakada, M. T.; Amin, K.; Christofidou-Solomidou, M.; O'Brien, C. D.; Sun, J.; Gurubhagavatula, I.; Heavner, G. A.; Taylor, A. H.; Paddock, C.; Sun, Q. H. et al. Antibodies against the First Ig-Like Domain of Human Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) That Inhibit PECAM-1-Dependent Homophilic Adhesion Block in Vivo Neutrophil Recruitment J. Immunol. 2000, 164, 452-462
238. Murohara, T.; Delyani, J. A.; Albelda, S. M.; Lefer, A. M. Blockade of Platelet Endothelial Cell Adhesion Molecule-1 Protects against Myocardial Ischemia and Reperfusion Injury in Cats J. Immunol. 1996, 156, 3550-3557
239. Muro, S.; Gajewski, C.; Koval, M.; Muzykantov, V. R. ICAM-1 Recycling in Endothelial Cells: A Novel Pathway for Sustained Intracellular Delivery and Prolonged Effects of Drugs Blood 2005, 105, 650-658
240. Panes, J.; Perry, M. A.; Anderson, D. C.; Muzykantov, V. R.; Carden, D. L.; Miyasaka, M.; Granger, D. N. Portal Hypertension Enhances Endotoxin-Induced Intercellular Adhesion Molecule 1 Up-Regulation in the Rat Gastroenterology 1996, 110, 866-874
241. Murciano, J. C.; Muro, S.; Koniaris, L.; Christofidou-Solomidou, M.; Harshaw, D. W.; Albelda, S. M.; Granger, D. N.; Cines, D. B.; Muzykantov, V. R. ICAM-Directed Vascular Immunotargeting of Antithrombotic Agents to the Endothelial Luminal Surface Blood 2003, 101, 3977-3984
242. Scherpereel, A.; Wiewrodt, R.; Christofidou-Solomidou, M.; Gervais, R.; Murciano, J. C.; Albelda, S. M.; Muzykantov, V. R. Cell-Selective Intracellular Delivery of a Foreign Enzyme to Endothelium in Vivo Using Vascular Immunotargeting FASEB J. 2001, 15, 416-426
243. Muro, S.; Dziubla, T.; Qiu, W.; Leferovich, J.; Cui, X.; Berk, E.; Muzykantov, V. R. Endothelial Targeting of High-Affinity Multivalent Polymer Nanocarriers Directed to Intercellular Adhesion Molecule 1 J. Pharmacol. Exp. Ther. 2006, 317, 1161-1169
244. Garnacho, C.; Dhami, R.; Simone, E.; Dziubla, T.; Leferovich, J.; Schuchman, E. H.; Muzykantov, V.; Muro, S. Delivery of Acid Sphingomyelinase in Normal and Niemann-Pick Disease Mice Using Intercellular Adhesion Molecule-1-Targeted Polymer Nanocarriers J. Pharmacol. Exp. Ther. 2008, 325, 400-408
245. Hua, S.; Chang, H. I.; Davies, N. M.; Cabot, P. J. Targeting of ICAM-1-Directed Immunoliposomes Specifically to Activated Endothelial Cells with Low Cellular Uptake: Use of an Optimized Procedure for the Coupling of Low Concentrations of Antibody to Liposomes J. Liposome Res. 2011, 21, 95-105
246. Ding, B. S.; Gottstein, C.; Grunow, A.; Kuo, A.; Ganguly, K.; Albelda, S. M.; Cines, D. B.; Muzykantov, V. R. Endothelial Targeting of a Recombinant Construct Fusing a PECAM-1 Single-Chain Variable Antibody Fragment (Scfv) with Prourokinase Facilitates Prophylactic Thrombolysis in the Pulmonary Vasculature Blood 2005, 106, 4191-4198
247. Belizaire, A. K.; Tchistiakova, L.; St-Pierre, Y.; Alakhov, V. Identification of a Murine ICAM-1-Specific Peptide by Subtractive Phage Library Selection on Cells Biochem. Biophys. Res. Commun. 2003, 309, 625-630
248. Luo, G. X.; Kohlstaedt, L. A.; Charles, C. H.; Gorfain, E.; Morantte, I.; Williams, J. H.; Fang, F. Humanization of an Anti-ICAM-1 Antibody with over 50-fold Affinity and Functional Improvement J. Immunol. Methods 2003, 275, 31-40
249. Charles, C. H.; Luo, G. X.; Kohlstaedt, L. A.; Morantte, I. G.; Gorfain, E.; Cao, L.; Williams, J. H.; Fang, F. Prevention of Human Rhinovirus Infection by Multivalent Fab Molecules Directed against ICAM-1 Antimicrob. Agents Chemother. 2003, 47, 1503-1508
250. Furuya, K.; Takeda, H.; Azhar, S.; McCarron, R. M.; Chen, Y.; Ruetzler, C. A.; Wolcott, K. M.; DeGraba, T. J.; Rothlein, R.; Hugli, T. E. et al. Examination of Several Potential Mechanisms for the Negative Outcome in a Clinical Stroke Trial of Enlimomab, a Murine Anti-Human Intercellular Adhesion Molecule-1 Antibody: A Bedside-to-Bench Study Stroke 2001, 32, 2665-2674
251. Rothlein, R.; Mainolfi, E. A.; Kishimoto, T. K. Treatment of Inflammation with Anti-ICAM-1 Res. Immunol. 1993, 144, 735-739
252. discussion 754-762.
253. Garnacho, C.; Serrano, D.; Muro, S. A Fibrinogen-Derived Peptide Provides Intercellular Adhesion Molecule-1-Specific Targeting and Intraendothelial Transport of Polymer Nanocarriers in Human Cell Cultures and Mice J. Pharmacol. Exp. Ther. 2012, 340, 638-647
254. Liu, J.; Weller, G. E.; Zern, B.; Ayyaswamy, P. S.; Eckmann, D. M.; Muzykantov, V. R.; Radhakrishnan, R. Computational Model for Nanocarrier Binding to Endothelium Validated Using in Vivo, in Vitro, and Atomic Force Microscopy Experiments Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 16530-16535
255. Charoenphol, P.; Huang, R. B.; Eniola-Adefeso, O. Potential Role of Size and Hemodynamics in the Efficacy of Vascular-Targeted Spherical Drug Carriers Biomaterials 2010, 31, 1392-1402
256. Blackwell, J. E.; Dagia, N. M.; Dickerson, J. B.; Berg, E. L.; Goetz, D. J. Ligand Coated Nanosphere Adhesion to E- and P-Selectin under Static and Flow Conditions Ann. Biomed. Eng. 2001, 29, 523-533
257. Swaminathan, T. N.; Liu, J.; Balakrishnan, U.; Ayyaswamy, P. S.; Radhakrishnan, R.; Eckmann, D. M. Dynamic Factors Controlling Carrier Anchoring on Vascular Cells IUBMB Life 2011, 63, 640-647
258. Omolola Eniola, A.; Hammer, D. A. In Vitro Characterization of Leukocyte Mimetic for Targeting Therapeutics to the Endothelium Using Two Receptors Biomaterials 2005, 26, 7136-7144
259. Charoenphol, P.; Onyskiw, P. J.; Carrasco-Teja, M.; Eniola-Adefeso, O. Particle-Cell Dynamics in Human Blood Flow: Implications for Vascular-Targeted Drug Delivery J. Biomechanics 2012, 45, 2822-2828
260. Namdee, K.; Thompson, A. J.; Charoenphol, P.; Eniola-Adefeso, O. Margination Propensity of Vascular-Targeted Spheres from Blood Flow in a Microfluidic Model of Human Microvessels Langmuir 2013, 29, 2530-2535
261. Kiani, M. F.; Yuan, H.; Chen, X.; Smith, L.; Gaber, M. W.; Goetz, D. J. Targeting Microparticles to Select Tissue via Radiation-Induced Upregulation of Endothelial Cell Adhesion Molecules Pharm. Res. 2002, 19, 1317-1322
262. Sakhalkar, H. S.; Hanes, J.; Fu, J.; Benavides, U.; Malgor, R.; Borruso, C. L.; Kohn, L. D.; Kurjiaka, D. T.; Goetz, D. J. Enhanced Adhesion of Ligand-Conjugated Biodegradable Particles to Colitic Venules FASEB J. 2005, 19, 792-794
263. Sakhalkar, H. S.; Dalal, M. K.; Salem, A. K.; Ansari, R.; Fu, J.; Kiani, M. F.; Kurjiaka, D. T.; Hanes, J.; Shakesheff, K. M.; Goetz, D. J. Leukocyte-Inspired Biodegradable Particles That Selectively and Avidly Adhere to Inflamed Endothelium in Vitro and in Vivo Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 15895-15900
264. Lin, A.; Sabnis, A.; Kona, S.; Nattama, S.; Patel, H.; Dong, J.-F.; Nguyen, K. T. Shear-Regulated Uptake of Nanoparticles by Endothelial Cells and Development of Endothelial-Targeting Nanoparticles J. Biomed. Mater. Res., Part A 2010, 93A, 833-842
265. Decuzzi, P.; Lee, S.; Bhushan, B.; Ferrari, M. A Theoretical Model for the Margination of Particles within Blood Vessels Ann. Biomed. Eng. 2005, 33, 179-190
266. Gentile, F.; Curcio, A.; Indolfi, C.; Ferrari, M.; Decuzzi, P. The Margination Propensity of Spherical Particles for Vascular Targeting in the Microcirculation J. Nanobiotechnol. 2008, 6, 9
267. Desjardins, C.; Duling, B. R. Heparinase Treatment Suggests a Role for the Endothelial Cell Glycocalyx in Regulation of Capillary Hematocrit Am. J. Physiol. 1990, 258, H647-654
268. Samokhin, G. P.; Smirnov, M. D.; Muzykantov, V. R.; Domogatsky, S. P.; Smirnov, V. N. Red Blood Cell Targeting to Collagen-Coated Surfaces FEBS Lett. 1983, 154, 257-261
269. Zhang, J.; Johnson, P. C.; Popel, A. S. Effects of Erythrocyte Deformability and Aggregation on the Cell Free Layer and Apparent Viscosity of Microscopic Blood Flows Microvasc. Res. 2009, 77, 265-272
270. Tan, J.; Thomas, A.; Liu, Y. Influence of Red Blood Cells on Nanoparticle Targeted Delivery in Microcirculation Soft Matter 2011, 8, 1934-1946
271. Chrastina, A.; Valadon, P.; Massey, K. A.; Schnitzer, J. E. Lung Vascular Targeting Using Antibody to Aminopeptidase P: Ct-Spect Imaging, Biodistribution and Pharmacokinetic Analysis J. Vasc. Res. 2010, 47, 531-543
272. Kolhar, P.; Anselmo, A. C.; Gupta, V.; Pant, K.; Prabhakarpandian, B.; Ruoslahti, E.; Mitragotri, S. Using Shape Effects to Target Antibody-Coated Nanoparticles to Lung and Brain Endothelium Proc. Natl. Acad. Sci. U.S.A. 2013, 110, 10753-10758
273. Prabhakarpandian, B.; Pant, K.; Scott, R. C.; Patillo, C. B.; Irimia, D.; Kiani, M. F.; Sundaram, S. Synthetic Microvascular Networks for Quantitative Analysis of Particle Adhesion Biomed. Microdevices 2008, 10, 585-595
274. Decuzzi, P.; Ferrari, M. The Adhesive Strength of Non-Spherical Particles Mediated by Specific Interactions Biomaterials 2006, 27, 5307-5314
275. Decuzzi, P.; Ferrari, M. The Role of Specific and Non-Specific Interactions in Receptor-Mediated Endocytosis of Nanoparticles Biomaterials 2007, 28, 2915-2922
276. Doshi, N.; Prabhakarpandian, B.; Rea-Ramsey, A.; Pant, K.; Sundaram, S.; Mitragotri, S. Flow and Adhesion of Drug Carriers in Blood Vessels Depend on Their Shape: A Study Using Model Synthetic Microvascular Networks J. Controlled Release 2010, 146, 196-200
277. Rosano, J. M.; Tousi, N.; Scott, R. C.; Krynska, B.; Rizzo, V.; Prabhakarpandian, B.; Pant, K.; Sundaram, S.; Kiani, M. F. A Physiologically Realistic in Vitro Model of Microvascular Networks Biomed. Microdevices 2009, 11, 1051-1057
278. Shah, S.; Liu, Y.; Hu, W.; Gao, J. Modeling Particle Shape-Dependent Dynamics in Nanomedicine J. Nanosci. Nanotechnol. 2011, 11, 919-928
279. Gentile, F.; Chiappini, C.; Fine, D.; Bhavane, R. C.; Peluccio, M. S.; Cheng, M. M.; Liu, X.; Ferrari, M.; Decuzzi, P. The Effect of Shape on the Margination Dynamics of Non-Neutrally Buoyant Particles in Two-Dimensional Shear Flows J. Biomechanics 2008, 41, 2312-2318
280. Gunawan, R. C.; Auguste, D. T. The Role of Antibody Synergy and Membrane Fluidity in the Vascular Targeting of Immunoliposomes Biomaterials 2010, 31, 900-907
281. Doshi, N.; Orje, J. N.; Molins, B.; Smith, J. W.; Mitragotri, S.; Ruggeri, Z. M. Platelet Mimetic Particles for Targeting Thrombi in Flowing Blood Adv. Mater. 2012, 24, 3864-3869
282. Beningo, K. A.; Wang, Y.-l. Fc-Receptor-Mediated Phagocytosis Is Regulated by Mechanical Properties of the Target J. Cell Sci. 2002, 115, 849-856
283. Trubetskoy, V. S.; Narula, J.; Khaw, B. A.; Torchilin, V. P. Chemically Optimized Antimyosin Fab Conjugates with Chelating Polymers: Importance of the Nature of the Protein-Polymer Single Site Covalent Bond for Biodistribution and Infarction Localization Bioconjugate Chem. 1993, 4, 251-255
284. Muro, S. New Biotechnological and Nanomedicine Strategies for Treatment of Lysosomal Storage Disorders Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol. 2010, 2, 189-204
285. Calderon, A. J.; Bhowmick, T.; Leferovich, J.; Burman, B.; Pichette, B.; Muzykantov, V.; Eckmann, D. M.; Muro, S. Optimizing Endothelial Targeting by Modulating the Antibody Density and Particle Concentration of Anti-ICAM Coated Carriers J. Controlled Release 2011, 150, 37-44
286. Adams, G. P.; Tai, M. S.; McCartney, J. E.; Marks, J. D.; Stafford, W. F., III; Houston, L. L.; Huston, J. S.; Weiner, L. M. Avidity-Mediated Enhancement of in Vivo Tumor Targeting by Single-Chain Fv Dimers Clin. Cancer Res. 2006, 12, 1599-1605
287. Cheng, Z.; Al Zaki, A.; Hui, J. Z.; Muzykantov, V. R.; Tsourkas, A. Multifunctional Nanoparticles: Cost versus Benefit of Adding Targeting and Imaging Capabilities Science 2012, 338, 903-910
288. Irvine, D. J.; Swartz, M. A.; Szeto, G. L. Engineering Synthetic Vaccines Using Cues from Natural Immunity Nat. Mater. 2013, 12, 978-990
289. Liu, H.; Moynihan, K. D.; Zheng, Y.; Szeto, G. L.; Li, A. V.; Huang, B.; Van Egeren, D. S.; Park, C.; Irvine, D. J. Structure-Based Programming of Lymph-Node Targeting in Molecular Vaccines Nature 2014, 507, 519-522
290. Metcalfe, S. M.; Fahmy, T. M. Targeted Nanotherapy for Induction of Therapeutic Immune Responses Trends Mol. Med. 2012, 18, 72-80
291. Adams, G. P.; Schier, R.; McCall, A. M.; Simmons, H. H.; Horak, E. M.; Alpaugh, R. K.; Marks, J. D.; Weiner, L. M. High Affinity Restricts the Localization and Tumor Penetration of Single-Chain Fv Antibody Molecules Cancer Res. 2001, 61, 4750-4755
292. Sakharov, D. V.; Rijken, D. C. Superficial Accumulation of Plasminogen During Plasma Clot Lysis Circulation 1995, 92, 1883-1890
293. Elias, D. R.; Poloukhtine, A.; Popik, V.; Tsourkas, A. Effect of Ligand Density, Receptor Density, and Nanoparticle Size on Cell Targeting Nanomedicine 2013, 9, 194-201
294. Fakhari, A.; Baoum, A.; Siahaan, T. J.; Le, K. B.; Berkland, C. Controlling Ligand Surface Density Optimizes Nanoparticle Binding to ICAM-1 J. Pharm. Sci. 2011, 100, 1045-1056
295. Gu, F.; Zhang, L.; Teply, B. A.; Mann, N.; Wang, A.; Radovic-Moreno, A. F.; Langer, R.; Farokhzad, O. C. Precise Engineering of Targeted Nanoparticles by Using Self-Assembled Biointegrated Block Copolymers Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 2586-2591
296. Levi, M.; Friederich, P. W.; Middleton, S.; de Groot, P. G.; Wu, Y. P.; Harris, R.; Biemond, B. J.; Heijnen, H. F.; Levin, J.; ten Cate, J. W. Fibrinogen-Coated Albumin Microcapsules Reduce Bleeding in Severely Thrombocytopenic Rabbits Nat. Med. 1999, 5, 107-111
297. Bertram, J. P.; Williams, C. A.; Robinson, R.; Segal, S. S.; Flynn, N. T.; Lavik, E. B. Intravenous Hemostat: Nanotechnology to Halt Bleeding Sci. Transl. Med. 2009, 1, 11ra22
298. Modery-Pawlowski, C. L.; Tian, L. L.; Ravikumar, M.; Wong, T. L.; Sen Gupta, A. In Vitro and in Vivo Hemostatic Capabilities of a Functionally Integrated Platelet-Mimetic Liposomal Nanoconstruct Biomaterials 2013, 34, 3031-3041
299. Modery-Pawlowski, C. L.; Tian, L. L.; Pan, V.; McCrae, K. R.; Mitragotri, S.; Sen Gupta, A. Approaches to Synthetic Platelet Analogs Biomaterials 2012, 34, 526-541
300. Lashof-Sullivan, M.; Shoffstall, A.; Lavik, E. Intravenous Hemostats: Challenges in Translation to Patients Nanoscale 2013, 5, 10719-10728
301. Shoffstall, A. J.; Everhart, L. M.; Varley, M. E.; Soehnlen, E. S.; Shick, A. M.; Ustin, J. S.; Lavik, E. B. Tuning Ligand Density on Intravenous Hemostatic Nanoparticles Dramatically Increases Survival Following Blunt Trauma Biomacromolecules 2013, 14, 2790-2797
302. Sun, D.; Nakao, S.; Xie, F.; Zandi, S.; Schering, A.; Hafezi-Moghadam, A. Superior Sensitivity of Novel Molecular Imaging Probe: Simultaneously Targeting Two Types of Endothelial Injury Markers FASEB J. 2010, 24, 1532-1540
303. Eniola, A. O.; Willcox, P. J.; Hammer, D. A. Interplay between Rolling and Firm Adhesion Elucidated with a Cell-Free System Engineered with Two Distinct Receptor-Ligand Pairs Biophys. J. 2003, 85, 2720-2731
304. Gunawan, R. C.; Auguste, D. T. Immunoliposomes That Target Endothelium in Vitro Are Dependent on Lipid Raft Formation Mol. Pharmaceutics 2010, 7, 1569-1575
305. Gunawan, R. C.; Almeda, D.; Auguste, D. T. Complementary Targeting of Liposomes to Il-1alpha and Tnf-Alpha Activated Endothelial Cells via the Transient Expression of Vcam1 and E-Selectin Biomaterials 2011, 32, 9848-9853
306. Papademetriou, I. T.; Garnacho, C.; Schuchman, E. H.; Muro, S. In Vivo Performance of Polymer Nanocarriers Dually-Targeted to Epitopes of the Same or Different Receptors Biomaterials 2013, 34, 3459-3466
307. McAteer, M. A.; Schneider, J. E.; Ali, Z. A.; Warrick, N.; Bursill, C. A.; von zur Muhlen, C.; Greaves, D. R.; Neubauer, S.; Channon, K. M.; Choudhury, R. P. Magnetic Resonance Imaging of Endothelial Adhesion Molecules in Mouse Atherosclerosis Using Dual-Targeted Microparticles of Iron Oxide Arterioscler., Thromb., Vasc. Biol. 2008, 28, 77-83
308. Weller, G. E.; Villanueva, F. S.; Tom, E. M.; Wagner, W. R. Targeted Ultrasound Contrast Agents: In Vitro Assessment of Endothelial Dysfunction and Multi-Targeting to ICAM-1 and Sialyl Lewisx Biotechnol. Bioeng. 2005, 92, 780-788
309. Danilov, S.; Jaspard, E.; Churakova, T.; Towbin, H.; Savoie, F.; Wei, L.; Alhenc-Gelas, F. Structure-Function Analysis of Angiotensin I-Converting Enzyme Using Monoclonal Antibodies. Selective Inhibition of the Amino-Terminal Active Site J. Biol. Chem. 1994, 269, 26806-26814
310. Balyasnikova, I. V.; Karran, E. H.; Albrecht, R. F., II; Danilov, S. M. Epitope-Specific Antibody-Induced Cleavage of Angiotensin-Converting Enzyme from the Cell Surface Biochem. J. 2002, 362, 585-595
311. Gordon, K.; Balyasnikova, I. V.; Nesterovitch, A. B.; Schwartz, D. E.; Sturrock, E. D.; Danilov, S. M. Fine Epitope Mapping of Monoclonal Antibodies 9b9 and 3g8 to the N Domain of Angiotensin-Converting Enzyme (Cd143) Defines a Region Involved in Regulating Angiotensin-Converting Enzyme Dimerization and Shedding Tissue Antigens 2010, 75, 136-150
312. Chacko, A. M.; Nayak, M.; Greineder, C. F.; Delisser, H. M.; Muzykantov, V. R. Collaborative Enhancement of Antibody Binding to Distinct PECAM-1 Epitopes Modulates Endothelial Targeting PLoS One 2012, 7 e34958
313. Chen, X. Y.; Wang, S. M.; Li, N.; Hu, Y.; Zhang, Y.; Xu, J. F.; Li, X.; Ren, J.; Su, B.; Yuan, W. Z.; Teng, X. R.; Zhang, R. X.; Jiang, D. H.; Mulet, X.; Li, H. P. Creation of Lung-Targeted Dexamethasone Immunoliposome and Its Therapeutic Effect on Bleomycin-Induced Lung Injury in Rats PLoS One 2013, 8 e58275
314. Aird, W. C.; Kwaan, H. C. Under-Recognized Significance of Endothelial Heterogeneity: Hemostasis, Thrombosis, and Beyond Semin. Thromb. Hemostasis 2010, 36, 225-226
315. Schnitzer, J. E. Caveolae: From Basic Trafficking Mechanisms to Targeting Transcytosis for Tissue-Specific Drug and Gene Delivery in Vivo Adv. Drug Delivery Rev. 2001, 49, 265-280
316. Balyasnikova, I. V.; Danilov, S. M.; Muzykantov, V. R.; Fisher, A. B. Modulation of Angiotensin-Converting Enzyme in Cultured Human Vascular Endothelial Cells In Vitro Cell. Dev. Biol.: Anim. 1998, 34, 545-554
317. Biswas, S.; Torchilin, V. P. Nanopreparations for Organelle-Specific Delivery in Cancer Adv. Drug Delivery Rev. 2013, 66, 26-41
318. Agarwal, R.; Roy, K. Intracellular Delivery of Polymeric Nanocarriers: A Matter of Size, Shape, Charge, Elasticity and Surface Composition Ther. Delivery 2013, 4, 705-723
319. Predescu, S. A.; Predescu, D. N.; Malik, A. B. Molecular Determinants of Endothelial Transcytosis and Their Role in Endothelial Permeability Am. J. Physiol.: Lung Cell. Mol. Physiol. 2007, 293, L823-842
320. Mukherjee, S.; Ghosh, R. N.; Maxfield, F. R. Endocytosis Physiol. Rev. 1997, 77, 759-803
321. Caron, E.; Hall, A. Phagocytosis; Oxford University Press: Oxford, U.K., 2001; p 58-77.
322. Popova, N. V.; Deyev, I. E.; Petrenko, A. G. Clathrin-Mediated Endocytosis and Adaptor Proteins Acta Nat. 2013, 5, 62-73
323. Mellman, I. Endocytosis and Molecular Sorting Annu. Rev. Cell Dev. Biol. 1996, 12, 575-625
324. Minshall, R. D.; Tiruppathi, C.; Vogel, S. M.; Niles, W. D.; Gilchrist, A.; Hamm, H. E.; Malik, A. B. Endothelial Cell-Surface Gp60 Activates Vesicle Formation and Trafficking via G(I)-Coupled Src Kinase Signaling Pathway J. Cell Biol. 2000, 150, 1057-1070
325. Predescu, D.; Predescu, S.; Malik, A. B. Transport of Nitrated Albumin across Continuous Vascular Endothelium Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 13932-13937
326. Koval, M.; Preiter, K.; Adles, C.; Stahl, P. D.; Steinberg, T. H. Size of Igg-Opsonized Particles Determines Macrophage Response During Internalization Exp. Cell Res. 1998, 242, 265-273
327. Wiewrodt, R.; Thomas, A. P.; Cipelletti, L.; Christofidou-Solomidou, M.; Weitz, D. A.; Feinstein, S. I.; Schaffer, D.; Albelda, S. M.; Koval, M.; Muzykantov, V. R. Size-Dependent Intracellular Immunotargeting of Therapeutic Cargoes into Endothelial Cells Blood 2002, 99, 912-922
328. Everts, M.; Kok, R. J.; Asgeirsdottir, S. A.; Melgert, B. N.; Moolenaar, T. J.; Koning, G. A.; van Luyn, M. J.; Meijer, D. K.; Molema, G. Selective Intracellular Delivery of Dexamethasone into Activated Endothelial Cells Using an E-Selectin-Directed Immunoconjugate J. Immunol. 2002, 168, 883-889
329. Ricard, I.; Payet, M. D.; Dupuis, G. Vcam-1 Is Internalized by a Clathrin-Related Pathway in Human Endothelial Cells but Its Alpha 4 Beta 1 Integrin Counter-Receptor Remains Associated with the Plasma Membrane in Human T Lymphocytes Eur. J. Immunol. 1998, 28, 1708-1718
330. Pardridge, W. M. Blood-Brain Barrier Drug Targeting: The Future of Brain Drug Development Mol. Interventions 2003, 3, 90-105
331. Tagliabue, E.; Centis, F.; Campiglio, M.; Mastroianni, A.; Martignone, S.; Pellegrini, R.; Casalini, P.; Lanzi, C.; Menard, S.; Colnaghi, M. I. Selection of Monoclonal Antibodies Which Induce Internalization and Phosphorylation of P185her2 and Growth Inhibition of Cells with Her2/Neu Gene Amplification Int. J. Cancer 1991, 47, 933-937
332. Feero, W. G.; Li, S.; Rosenblatt, J. D.; Sirianni, N.; Morgan, J. E.; Partridge, T. A.; Huang, L.; Hoffman, E. P. Selection and Use of Ligands for Receptor-Mediated Gene Delivery to Myogenic Cells Gene Ther. 1997, 4, 664-674
333. Zhou, Y.; Zhao, L.; Marks, J. D. Selection and Characterization of Cell Binding and Internalizing Phage Antibodies Arch. Biochem. Biophys. 2012, 526, 107-113
334. Zhou, Y.; Zou, H.; Zhang, S.; Marks, J. D. Internalizing Cancer Antibodies from Phage Libraries Selected on Tumor Cells and Yeast-Displayed Tumor Antigens J. Mol. Biol. 2010, 404, 88-99
335. Heitner, T.; Moor, A.; Garrison, J. L.; Marks, C.; Hasan, T.; Marks, J. D. Selection of Cell Binding and Internalizing Epidermal Growth Factor Receptor Antibodies from a Phage Display Library J. Immunol. Methods 2001, 248, 17-30
336. Anderson, D. C.; Manger, R.; Schroeder, J.; Woodle, D.; Barry, M.; Morgan, A. C.; Fritzberg, A. R. Enhanced in Vitro Tumor Cell Retention and Internalization of Antibody Derivatized with Synthetic Peptides Bioconjugate Chem. 1993, 4, 10-18
337. Couch, J. A.; Yu, Y. J.; Zhang, Y.; Tarrant, J. M.; Fuji, R. N.; Meilandt, W. J.; Solanoy, H.; Tong, R. K.; Hoyte, K.; Luk, W. et al. Addressing Safety Liabilities of Tfr Bispecific Antibodies That Cross the Blood-Brain Barrier Sci. Transl. Med. 2013, 5, 183ra57
338. Ilan, N.; Mohsenin, A.; Cheung, L.; Madri, J. A. PECAM-1 Shedding During Apoptosis Generates a Membrane-Anchored Truncated Molecule with Unique Signaling Characteristics FASEB J. 2001, 15, 362-372
339. Muro, S.; Wiewrodt, R.; Thomas, A.; Koniaris, L.; Albelda, S. M.; Muzykantov, V. R.; Koval, M. A Novel Endocytic Pathway Induced by Clustering Endothelial ICAM-1 or PECAM-1 J. Cell Sci. 2003, 116, 1599-1609
340. Muro, S.; Muzykantov, V. R.; Murciano, J. C. Characterization of Endothelial Internalization and Targeting of Antibody-Enzyme Conjugates in Cell Cultures and in Laboratory Animals Methods Mol. Biol. 2004, 283, 21-36
341. Ding, B. S.; Hong, N.; Christofidou-Solomidou, M.; Gottstein, C.; Albelda, S. M.; Cines, D. B.; Fisher, A. B.; Muzykantov, V. R. Anchoring Fusion Thrombomodulin to the Endothelial Lumen Protects against Injury-Induced Lung Thrombosis and Inflammation Am. J. Respir. Crit. Care Med. 2009, 180, 247-256
342. Pelkmans, L.; Helenius, A. Endocytosis via Caveolae Traffic 2002, 3, 311-320
343. Kolhar, P.; Mitragotri, S. Polymer Microparticles Exhibit Size and Shape Dependent Accumulation around the Nucleus after Endocytosis Adv. Funct. Mater. 2012, 22, 3759-3764
344. Kolhar, P.; Doshi, N.; Mitragotri, S. Polymer Nanoneedle-Mediated Intracellular Drug Delivery Small 2011, 7, 2094-2100
345. Gratton, S. E.; Ropp, P. A.; Pohlhaus, P. D.; Luft, J. C.; Madden, V. J.; Napier, M. E.; DeSimone, J. M. The Effect of Particle Design on Cellular Internalization Pathways Proc. Natl. Acad.Sci. U.S.A. 2008, 105, 11613-11618
346. Bhowmick, T.; Berk, E.; Cui, X.; Muzykantov, V. R.; Muro, S. Effect of Flow on Endothelial Endocytosis of Nanocarriers Targeted to ICAM-1 J. Controlled Release 2012, 157, 485-492
347. Samuel, S. P.; Jain, N.; O'Dowd, F.; Paul, T.; Kashanin, D.; Gerard, V. A.; Gun'ko, Y. K.; Prina-Mello, A.; Volkov, Y. Multifactorial Determinants That Govern Nanoparticle Uptake by Human Endothelial Cells under Flow Int. J. Nanomed. 2012, 7, 2943-2956
348. Terrisse, A. D.; Puech, N.; Allart, S.; Gourdy, P.; Xuereb, J. M.; Payrastre, B.; Sie, P. Internalization of Microparticles by Endothelial Cells Promotes Platelet/Endothelial Cell Interaction under Flow J. Thromb. Haemost. 2010, 8, 2810-2819
349. Han, J.; Zern, B. J.; Shuvaev, V. V.; Davies, P. F.; Muro, S.; Muzykantov, V. Acute and Chronic Shear Stress Differently Regulate Endothelial Internalization of Nanocarriers Targeted to Platelet-Endothelial Cell Adhesion Molecule-1 ACS Nano 2012, 6, 8824-8836
350. Serrano, D.; Bhowmick, T.; Chadha, R.; Garnacho, C.; Muro, S. Intercellular Adhesion Molecule 1 Engagement Modulates Sphingomyelinase and Ceramide, Supporting Uptake of Drug Carriers by the Vascular Endothelium Arterioscler., Thromb., Vasc. Biol. 2012, 32, 1178-1185
351. Ansar, M.; Serrano, D.; Papademetriou, I.; Bhowmick, T. K.; Muro, S. Biological Functionalization of Drug Delivery Carriers to Bypass Size Restrictions of Receptor-Mediated Endocytosis Independently from Receptor Targeting ACS Nano 2013, 7, 10597-10611
352. Zhang, Y.; Schlachetzki, F.; Pardridge, W. M. Global Non-Viral Gene Transfer to the Primate Brain Following Intravenous Administration Mol. Ther. 2003, 7, 11-18
353. Schnitzer, J. E.; Oh, P.; McIntosh, D. P. Role of Gtp Hydrolysis in Fission of Caveolae Directly from Plasma Membranes Science 1996, 274, 239-242
354. Vogel, S. M.; Easington, C. R.; Minshall, R. D.; Niles, W. D.; Tiruppathi, C.; Hollenberg, S. M.; Parrillo, J. E.; Malik, A. B. Evidence of Transcellular Permeability Pathway in Microvessels Microvasc. Res. 2001, 61, 87-101
355. Dvorak, A. M.; Feng, D. The Vesiculo-Vacuolar Organelle (Vvo). A New Endothelial Cell Permeability Organelle J. Histochem. Cytochem. 2001, 49, 419-432
356. Iversen, T. G.; Frerker, N.; Sandvig, K. Uptake of Ricinb-Quantum Dot Nanoparticles by a Macropinocytosis-Like Mechanism J. Nanobiotechnol. 2012, 10, 33
357. Wang, Z.; Tiruppathi, C.; Minshall, R. D.; Malik, A. B. Size and Dynamics of Caveolae Studied Using Nanoparticles in Living Endothelial Cells ACS Nano 2009, 3, 4110-4116
358. Schnitzer, J. E.; Liu, J.; Oh, P. Endothelial Caveolae Have the Molecular Transport Machinery for Vesicle Budding, Docking, and Fusion Including Vamp, Nsf, Snap, Annexins, and Gtpases J. Biol. Chem. 1995, 270, 14399-14404
359. Mehta, D.; Bhattacharya, J.; Matthay, M. A.; Malik, A. B. Integrated Control of Lung Fluid Balance Am. J. Physiol.: Lung Cell. Mol. Physiol. 2004, 287, L1081-1090
360. Ghaffarian, R.; Bhowmick, T.; Muro, S. Transport of Nanocarriers across Gastrointestinal Epithelial Cells by a New Transcellular Route Induced by Targeting ICAM-1 J. Controlled Release 2012, 163, 25-33
361. Mane, V.; Muro, S. Biodistribution and Endocytosis of ICAM-1-Targeting Antibodies versus Nanocarriers in the Gastrointestinal Tract in Mice Int. J. Nanomed. 2012, 7, 4223-4237
362. Neumeyer, A.; Bukowski, M.; Veith, M.; Lehr, C. M.; Daum, N. Propidium Iodide Labeling of Nanoparticles as a Novel Tool for the Quantification of Cellular Binding and Uptake Nanomedicine 2011, 7, 410-419
363. Shuvaev, V. V.; Dziubla, T.; Wiewrodt, R.; Muzykantov, V. R. Streptavidin-Biotin Crosslinking of Therapeutic Enzymes with Carrier Antibodies: Nanoconjugates for Protection against Endothelial Oxidative Stress Methods Mol. Biol. 2004, 283, 3-19
364. Garnacho, C.; Shuvaev, V.; Thomas, A.; McKenna, L.; Sun, J.; Koval, M.; Albelda, S.; Muzykantov, V.; Muro, S. Rhoa Activation and Actin Reorganization Involved in Endothelial Cam-Mediated Endocytosis of Anti-PECAM Carriers: Critical Role for Tyrosine 686 in the Cytoplasmic Tail of PECAM-1 Blood 2008, 111, 3024-3033
365. Kim, J. A.; Aberg, C.; Salvati, A.; Dawson, K. A. Role of Cell Cycle on the Cellular Uptake and Dilution of Nanoparticles in a Cell Population Nat. Nanotechnol. 2012, 7, 62-68
366. Georgieva, J. V.; Kalicharan, D.; Couraud, P. O.; Romero, I. A.; Weksler, B.; Hoekstra, D.; Zuhorn, I. S. Surface Characteristics of Nanoparticles Determine Their Intracellular Fate in and Processing by Human Blood-Brain Barrier Endothelial Cells in Vitro Mol. Ther. 2011, 19, 318-325
367. Kastl, L.; Sasse, D.; Wulf, V.; Hartmann, R.; Mircheski, J.; Ranke, C.; Carregal-Romero, S.; Martinez-Lopez, J. A.; Fernandez-Chacon, R.; Parak, W. J. et al. Multiple Internalization Pathways of Polyelectrolyte Multilayer Capsules into Mammalian Cells ACS Nano 2013, 7, 6605-6618
368. Vasdekis, A. E.; Scott, E. A.; O'Neil, C. P.; Psaltis, D.; Hubbell, J. A. Precision Intracellular Delivery Based on Optofluidic Polymersome Rupture ACS Nano 2012, 6, 7850-7857
369. Kardara, M.; Hatziantoniou, S.; Sfika, A.; Vassiliou, A. G.; Mourelatou, E.; Muagkou, C.; Armaganidis, A.; Roussos, C.; Orfanos, S. E.; Kotanidou, A. et al. Caveolar Uptake and Endothelial-Protective Effects of Nanostructured Lipid Carriers in Acid Aspiration Murine Acute Lung Injury Pharm. Res. 2013, 30, 1836-1847
370. Rejman, J.; Oberle, V.; Zuhorn, I. S.; Hoekstra, D. Size-Dependent Internalization of Particles via the Pathways of Clathrin- and Caveolae-Mediated Endocytosis Biochem. J. 2004, 377, 159-169
371. Minami, T.; Sugiyama, A.; Wu, S. Q.; Abid, R.; Kodama, T.; Aird, W. C. Thrombin and Phenotypic Modulation of the Endothelium Arterioscler., Thromb., Vasc. Biol. 2004, 24, 41-53
372. Comhair, S. A.; Xu, W.; Mavrakis, L.; Aldred, M. A.; Asosingh, K.; Erzurum, S. C. Human Primary Lung Endothelial Cells in Culture Am. J. Respir. Cell Mol. Biol. 2012, 46, 723-730
373. Wagner, S.; Zensi, A.; Wien, S. L.; Tschickardt, S. E.; Maier, W.; Vogel, T.; Worek, F.; Pietrzik, C. U.; Kreuter, J.; von Briesen, H. Uptake Mechanism of Apoe-Modified Nanoparticles on Brain Capillary Endothelial Cells as a Blood-Brain Barrier Model PLoS One 2012, 7, e32568
374. Yang, H.; Zhao, F.; Li, Y.; Xu, M.; Li, L.; Wu, C.; Miyoshi, H.; Liu, Y. Vcam-1-Targeted Core/Shell Nanoparticles for Selective Adhesion and Delivery to Endothelial Cells with Lipopolysaccharide-Induced Inflammation under Shear Flow and Cellular Magnetic Resonance Imaging in Vitro Int. J. Nanomed. 2013, 8, 1897-1906
375. Davies, P. F. Hemodynamic Shear Stress and the Endothelium in Cardiovascular Pathophysiology Nat. Clin. Pract. Cardiovasc. Med. 2009, 6, 16-26
376. Baker, B. M.; Trappmann, B.; Stapleton, S. C.; Toro, E.; Chen, C. S. Microfluidics Embedded within Extracellular Matrix to Define Vascular Architectures and Pattern Diffusive Gradients Lab Chip 2013, 13, 3246-3252
377. Kusunose, J.; Zhang, H.; Gagnon, M. K.; Pan, T.; Simon, S. I.; Ferrara, K. W. Microfluidic System for Facilitated Quantification of Nanoparticle Accumulation to Cells under Laminar Flow Ann. Biomed. Eng. 2013, 41, 89-99
378. Khan, O. F.; Chamberlain, M. D.; Sefton, M. V. Toward an in Vitro Vasculature: Differentiation of Mesenchymal Stromal Cells within an Endothelial Cell-Seeded Modular Construct in a Microfluidic Flow Chamber Tissue Eng., Part A 2012, 18, 744-756
379. Young, E. W.; Simmons, C. A. Macro- and Microscale Fluid Flow Systems for Endothelial Cell Biology Lab Chip 2010, 10, 143-160
380. Wadia, J. S.; Stan, R. V.; Dowdy, S. F. Transducible Tat-Ha Fusogenic Peptide Enhances Escape of Tat-Fusion Proteins after Lipid Raft Macropinocytosis Nat. Med. 2004, 10, 310-315
381. Elsaesser, A.; Barnes, C. A.; McKerr, G.; Salvati, A.; Lynch, I.; Dawson, K. A.; Howard, C. V. Quantification of Nanoparticle Uptake by Cells Using an Unbiased Sampling Method and Electron Microscopy Nanomedicine (London, U.K.) 2011, 6, 1189-1198
382. ur Rehman, Z.; Hoekstra, D.; Zuhorn, I. S. Mechanism of Polyplex- and Lipoplex-Mediated Delivery of Nucleic Acids: Real-Time Visualization of Transient Membrane Destabilization without Endosomal Lysis ACS Nano 2013, 7, 3767-3777
383. Fiandra, L.; Mazzucchelli, S.; De Palma, C.; Colombo, M.; Allevi, R.; Sommaruga, S.; Clementi, E.; Bellini, M.; Prosperi, D.; Corsi, F. Assessing the in Vivo Targeting Efficiency of Multifunctional Nanoconstructs Bearing Antibody-Derived Ligands ACS Nano 2013, 7, 6092-6102